Introduction {#s1}
============

Aging is a complex process that often impairs physiological and tissue function. Further, age is the most relevant risk factor for many prominent diseases and disorders, including cancers and neurodegenerative diseases ([@bib54]). Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved, cytoprotective degradative process in which a double membrane engulfs intracellular cargo for breakdown and recycling ([@bib10]; [@bib70]). The autophagy pathway has been directly implicated in aging in model organisms ([@bib11]; [@bib70]).

Neurons are post-mitotic, terminally differentiated cells that must maintain function in distal compartments throughout the lifetime of a human. These maintenance mechanisms may wane as a person ages, potentially contributing to neuronal dysfunction and death. Accordingly, misregulation of autophagy has been associated with multiple age-related neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS) ([@bib48]; [@bib56]; [@bib102]). Furthermore, specifically disrupting autophagy in neurons results in neurodegeneration in animal models ([@bib23]; [@bib30]; [@bib108]).

Despite the implication of this pathway in neurodegenerative disease, autophagy is best understood for its roles in maintaining cellular homeostasis in yeast and mammalian cells in response to acute stressors such as starvation ([@bib1]; [@bib21]; [@bib46]; [@bib69]; [@bib77]; [@bib99]). Much less is known about how autophagy is regulated in neurons. Robust, constitutive autophagy functions at a constant, basal level in neurons both in vitro and in vivo. Autophagosomes are generated distally at the axon terminal or synapse and are then actively transported back to the soma during maturation to a fully-acidified degradative compartment ([@bib16]; [@bib23]; [@bib24]; [@bib31]; [@bib40]; [@bib52]; [@bib79]; [@bib82]; [@bib103]; [@bib106]). In contrast to the pronounced induction of autophagy in other systems by cellular stressors, there is little evidence that neuronal autophagy is substantially upregulated by either proteomic stress ([@bib40]; [@bib98]) or nutrient deprivation ([@bib42]). While recent progress has firmly linked autophagy and aging ([@bib8]; [@bib22]), little is known about how this essential homeostatic mechanism in neurons is affected by aging.

Autophagosome biogenesis, conserved from yeast to humans, involves over 30 proteins that act in distinct protein complexes to engulf either bulk cytoplasm or specific cargo within a double-membrane. A signature autophagy protein, LC3B, is used to label autophagosomes, as it is processed to a lipidated form that becomes tightly associated with the limiting membrane of the developing autophagosome. We have previously used live imaging to examine autophagosome biogenesis in dorsal root ganglion (DRG) neurons from transgenic mice expressing GFP-LC3B ([@bib40]; [@bib41]). Importantly, the spatially-specific pathway for constitutive axonal autophagy that has been extensively characterized in DRG neurons ([@bib16]; [@bib40]; [@bib41]; [@bib98]) has been confirmed across multiple models, including hippocampal and cortical neurons in vitro ([@bib37]; [@bib41]) and motor, touch, and interneurons in vivo in *Drosophila* and *C. elegans* ([@bib8]; [@bib52]; [@bib79]; [@bib82]). However, unlike hippocampal or cortical neurons, which are typically isolated from embryonic or early postnatal rodents, DRG neurons can be isolated from mice of any age and grow robustly in culture following dissection. As rates of autophagosome biogenesis in DRG neurons model those seen in vivo ([@bib79]; [@bib82]) and longitudinal studies indicate biogenesis rates remain constant over time in neurons in vitro ([@bib41]), DRGs represent a powerful model system to investigate autophagosome formation in mammalian neurons from aged mice with high temporal and spatial resolution.

Young neurons appear to clear dysfunctional organelles and protein aggregates very efficiently ([@bib7]), but few studies have examined autophagy in aged neurons. Since age is the most relevant shared risk factor in neurodegenerative disease ([@bib54]), elucidating how autophagy changes in neurons with age is crucial to understanding neurodegenerative diseases.

Here, we examine how autophagy is altered with age in primary neurons from mice. We find that the rate of autophagosome biogenesis decreases in neurons with age. This decrease is not due to a change in the kinetics of either initiation or nucleation during autophagosome formation. Instead, we find that the majority of autophagosome biogenesis events in neurons from aged mice exhibit pronounced stalling, remaining ATG13-positive and failing to recruit lipidated LC3B with normal kinetics. We observe pronounced morphological differences in autophagic vesicles in neurons from aged mice, including an increased frequency of multilamellar membranes, similar to observations of neurons from the brains of aging Alzheimer's patients ([@bib55]). Importantly, depletion of WIPI2 in neurons from young adult mice was sufficient to decrease the rate of autophagosome biogenesis to that of aged mice, while overexpression of WIPI2B in neurons from aged mice was sufficient to return the rate of autophagosome biogenesis to that found in neurons from young adult mice. Further, we find that the rescue of autophagosome biogenesis depends on the phosphorylation state of WIPI2B at the isolation membrane, suggesting that dynamic phosphorylation of WIPI2B regulates autophagosome biogenesis. Thus, while the rate of autophagosome biogenesis decreases in aged neurons, this decrease can be rescued by the restoration of a single autophagy component, suggesting a novel therapeutic target for future studies.

Results {#s2}
=======

Autophagosome biogenesis at the axon terminal decreases with age {#s2-1}
----------------------------------------------------------------

Since impaired autophagy has been implicated in the pathogenesis of neurodegeneration and age is the most relevant risk factor for neurodegenerative disease, we used the GFP-LC3B probe to assess how biogenesis rates change with age in primary DRG neurons dissected from mice of four different ages: 1-month-old young mice, 3-month-old young adult mice, 16--17 month-old aged mice, and 24-month-old advanced aged mice. We produced robust cultures of DRG neurons harvested from mice aged from 1 to 24 months; neurons harvested from all ages extended long neurites, and we did not detect significant loss of viability with age (data not shown). We used live-cell spinning disk fluorescence microscopy to examine autophagosome biogenesis at the axon tips of DRG neurons in culture with high spatial and temporal specificity.

We identified autophagosome biogenesis events as the formation of discrete GFP-LC3B puncta visible above the background cytoplasmic GFP-LC3B signal ([Figure 1A](#fig1){ref-type="fig"}). These puncta enlarged over approximately three minutes to form a 1 μm autophagosome. Strikingly, we found that the rate of autophagosome biogenesis significantly decreased with age, corresponding to a 53% decrease in autophagosome biogenesis in aged neurons compared to neurons from young adult mice. Furthermore, the decrease was even more pronounced in neurons from advanced aged mice ([Figure 1B](#fig1){ref-type="fig"}). These data indicate that the rate of autophagosome biogenesis, as detected by the generation of GFP-LC3B-positive puncta, decreases in axon terminals with increasing age.

![Autophagosome biogenesis decreases with age and results in aberrant AV formation in mammalian neurons.\
(**A**) Time series of GFP-LC3B in the distal axon of a DRG neuron from a young adult mouse. Green and white arrowheads each follow one autophagosome biogenesis event. Retrograde is to the right. Scale bar, 2 μm. (**B**) Quantification of the rate of autophagic vesicle (AV) biogenesis (assayed by GFP-LC3B puncta formation per minute) in DRG neurons from young (one mo, light green), young adult (three mo, green), aged (16--17 mo, dark green), and advanced aged (24 mo, very dark green) mice (mean ± SEM; n ≥ 54 neurons from three biological replicates). \*\*\*p\<0.0005; \*\*\*\*p\<0.0001 by one-way ANOVA test with Tukey's multiple comparisons test. (**C--E**) Representative electron micrographs of autophagosomes in DRG distal tips from young adult mice. AVs are composed of a continuous double membrane enclosing engulfed cytoplasm. Scale bars, 200 nm. (**F--H**) Representative electron micrographs of autophagosomes in DRG distal tips from aged mice. AVs contain multiple, ruffled double membranes (**G, H**). Scale bars, 200 nm. (**I--J**) Electron micrographs of autophagosomes in the presynaptic compartment of neuromuscular junctions (NMJs) from young adult (**I**) and aged (**J**) mice. Scale bars, 100 nm. Arrowheads indicate multilamellar membranes in DRGs and NMJs.](elife-44219-fig1){#fig1}

In subsequent experiments, we focused on 16--17 month-old aged mice, given the significant decrease in the rate of autophagosome biogenesis observed at this time point relative to young adult mice and the relevance of this time point to the age of onset for age-associated neurodegenerative diseases such as ALS and AD.

Morphological differences are common in neuronal autophagosomes of aged mice {#s2-2}
----------------------------------------------------------------------------

To further characterize changes in autophagic vesicle (AV) biogenesis in neurons during aging, we used transmission electron microscopy to compare the ultrastructure of AVs at axon terminals of neurons from young adult and aged mice. We observed stereotypical double-membrane structures with heterogeneous contents in the axonal tips of neurons from young adult mice ([Figure 1C--E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A and C--E](#fig1s1){ref-type="fig"}). However, in neurons from aged mice we more frequently observed aberrant AVs with a multilamellar (onion skin-like) structure ([Figure 1F--H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1B and F--M](#fig1s1){ref-type="fig"}). Quantitative analysis indicated that only 34.0% of AVs (n = 153 AVs) observed in the distal tips of neurons from 16 to 17 month-old mice were morphologically normal, significantly different than the 80.4% of AVs judged to be morphologically normal in the axon tips of neurons from young adult mice (n = 56 AVs; p\<0.0001 by unpaired two-tailed Fisher's exact test). The aberrant morphology of AVs observed in aged mice suggested misregulated membrane extension during AV biogenesis, consistent with previous observations that failure to lipidate LC3 at isolation membranes prevented closure and inhibited the degradation of the inner autophagosome membrane ([@bib86]). Furthermore, these aberrant AVs were reminiscent of AVs previously observed in aged rodents ([@bib45]; [@bib44]) and in cortical biopsy specimens from patients with Alzheimer's disease ([@bib55]).

We next queried whether we could detect these age-related morphological differences in intact neuronal tissues, focusing on the prominent synapses that form between motor neurons and muscle at the neuromuscular junction (NMJ). We used NMJs from young adult and aged mice to assess any age-related changes in autophagosomes in vivo. Again, we observed stereotypical double-membrane structures with heterogeneous contents in neurons from young mice ([Figure 1I](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1O](#fig1s1){ref-type="fig"}). As we observed in DRG neurons in culture, we identified multilamellar structures in NMJs from aged mice in vivo ([Figure 1J](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1N and P](#fig1s1){ref-type="fig"}).

Pronounced stalling of autophagosome biogenesis is observed in aged neurons {#s2-3}
---------------------------------------------------------------------------

Autophagosome biogenesis can be divided into stages: initiation/induction, nucleation, elongation, and membrane closure ([Figure 2A](#fig2){ref-type="fig"}). The initiation complex, including ATG13 and ULK1/ATG1, induces autophagosome biogenesis by phosphorylating other autophagy components ([@bib14]; [@bib28]; [@bib68]). The nucleation complex, including VPS34 and ATG14, generates phosphatidylinositol 3-phosphate (PI3P) at the site of autophagosome biogenesis ([@bib29]; [@bib59]). Subsequently, the elongation complex, composed of two conjugation complexes, including ATG5, ATG12, and ATG16L1, is required to conjugate phosphatidylethanolamine (PE) to LC3 to yield LC3-II ([@bib85]). LC3-II is recruited to autophagosomes as the isolation membrane elongates during biogenesis and remains associated with autophagosomes until degradation of the internalized components. ATG9, a six-pass transmembrane protein, is thought to shuttle to the growing membrane with donor membrane ([@bib32]; [@bib60]; [@bib75]; [@bib83]; [@bib101]; [@bib105]). The ATG2 and WIPI4 complex is thought to work in concert with ATG9 to tether and provide lipids to the growing membrane ([@bib9]; [@bib18]; [@bib61]; [@bib88]; [@bib93]). Finally, the limiting membrane closes and fuses with itself to generate the unique double-membrane organelle. The autophagosome then undergoes retrograde transport along microtubules and subsequent fusion with lysosomes to degrade engulfed contents ([Figure 2A](#fig2){ref-type="fig"}) ([@bib100]).

![Early autophagosome biogenesis components do not change with age.\
(**A**) Schematic of autophagy pathway, focusing on the protein complexes involved in autophagosome biogenesis: induction (red), nucleation (blue), elongation (green), and ATG2/WIPI4 (yellow). ATG9, a multi-pass transmembrane protein is in purple. The product of the nucleation complex, PI3P, is depicted as a blue dot, while LC3-II, the product of the elongation complex, is depicted as a green dot. WIPI1 and WIPI2, which bind to PI3P, are displayed in orange. (**B**) Quantification of the rate of mCh-ATG13 puncta formation in live-cell imaging of DRG neurons from young, young adult, aged, and advanced aged mice (mean ± SEM; n ≥ 28 neurons from three biological replicates). ns, not significant by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**C--F**) Representative micrographs of mCh-ATG13 in the distal tip of DRG neurons from young (**C**), young adult (**D**), aged (**E**), and advanced aged (**F**) mice. (**G**) Quantification of the rate of Halo-DFCP1 puncta in DRG neurons from young, young adult, aged, and advanced aged mice (mean ± SEM; n ≥ 18 neurons from three biological replicates). ns, not significant by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**H--K**) Representative micrographs of Halo-DFCP1 in the distal tip of DRG neurons from young (**H**), young adult (**I**), aged (**J**), and advanced aged (**K**) mice. (**L**) Quantification of the rate of mCh-ATG5 puncta in DRG neurons from young, young adult, aged, and advanced aged mice (mean ± SEM; n ≥ 34 neurons from three biological replicates). ns, not significant; \*\*p\<0.001 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**M--P**) Representative micrographs of mCh-ATG5 in the distal tip of DRG neurons from young (**M**), young adult (**N**), aged (**O**), and advanced aged (**P**) mice. Scale bar in C, 2 μm, for C-F, H-K, M-P.](elife-44219-fig2){#fig2}

The observed decrease in the rate of autophagosome biogenesis that we measured by monitoring GFP-LC3B-positive puncta could result from alterations to the initiation, nucleation, or elongation complexes. To determine which stage of autophagosome biogenesis is affected by age, we used live-cell imaging to compare the kinetics of each step of the pathway ([Figure 2A](#fig2){ref-type="fig"}). We monitored the recruitment of the initiation complex by quantifying the appearance of fluorescent mCherry(mCh)-ATG13 puncta and observed similar kinetics of mCh-ATG13 recruitment in neurons from young, young adult, aged, and advanced aged mice ([Figure 2B--F](#fig2){ref-type="fig"}). To examine the kinetics of nucleation, we examined the recruitment of Double FYVE-containing protein 1 (DFCP1), which binds to PI3P, the product of the autophagy nucleation complex ([Figure 2A](#fig2){ref-type="fig"}). We did not detect a change in DFCP1 puncta formation with age ([Figure 2G--K](#fig2){ref-type="fig"}). We examined elongation with the marker mCh-ATG5, and again observed no change between neurons from young, young adult, and aged mice; we did observe a decrease in the rate of mCh-ATG5 puncta in neurons from advanced aged mice compared to young adult mice ([Figure 2L--P](#fig2){ref-type="fig"}). Together, these data demonstrate that the decrease in the rate of autophagosome formation with age is not due to an alteration in the kinetics of the early stages of biogenesis.

Next we used dual-color live cell imaging to compare assembly dynamics in neurons from young adult and aged mice co-expressing GFP-LC3B and initiation component mCh-ATG13. We observed 'productive' biogenesis events in neurons from aged mice ([Figure 3A](#fig3){ref-type="fig"}, [Video 1](#video1){ref-type="video"}), very similar to those previously described in neurons from young adult (4--6 month-old) mice ([@bib41]). Quantitative analysis of the change in fluorescence intensity over time ([Figure 3C](#fig3){ref-type="fig"}) indicated that mCh-ATG13 transiently localizes to these puncta for 100 to 150 s; subsequent recruitment of GFP-LC3B to a mCh-ATG13-positive punctum coincided with a loss in mCh-ATG13 signal intensity.

###### Productive biogenesis events in a neuron from an aged mouse.

GFP-LC3B and mCh-ATG13 in the distal neurite of a DRG neuron from an aged mouse depicting a productive autophagosome biogenesis event. In the merge movie (bottom), yellow arrowheads denote colocalization of ATG13 and LC3B; green arrowheads denote a LC3B-positive punctum from which ATG13 has dissociated; solid arrowheads track one punctum, hollow arrowheads follow a second punctum. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 3A](#fig3){ref-type="fig"}.

10.7554/eLife.44219.006

Frequently, however, dual labeling of autophagosome biogenesis in neurons from aged mice revealed 'stalled' events, in which mCh-ATG13 puncta formed and were stably maintained for at least 5 min of a 10 min video; we observed that these stalled events also failed to recruit GFP-LC3B within the imaging window ([Figure 3B and D](#fig3){ref-type="fig"} and [Video 2](#video2){ref-type="video"}). In neurons from young adult mice, greater than 75% of observed events were productive AVs ([Figure 3E](#fig3){ref-type="fig"}). In striking contrast, we found that stalled events dominated in neurons from aged mice, representing greater than 75% of total events in aged neurons ([Figure 3E](#fig3){ref-type="fig"}).

###### Stalled biogenesis events in a neuron from an aged mouse.

GFP-LC3B and mCh-ATG13 in the distal neurite of a DRG neuron from an aged mouse depicting a stalled autophagosome biogenesis event. In the merge movie (bottom), red arrowheads denote lack of colocalization between ATG13 and LC3B; solid arrowheads track one punctum, hollow arrowheads follow a second punctum. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 3B](#fig3){ref-type="fig"}.

10.7554/eLife.44219.007

We observed a similar distinction between productive and stalled events when we compared the recruitment kinetics of GFP-LC3B with elongation complex component mCh-ATG5 ([Figure 3F--G](#fig3){ref-type="fig"}; [Videos 3](#video3){ref-type="video"},[4](#video4){ref-type="video"}). In neurons from aged mice, we observed stereotypical AV kinetics, in which the transient recruitment of mCh-ATG5 over approximately 100 s is followed by a steady increase in GFP-LC3B intensity ([Figure 3H](#fig3){ref-type="fig"}), similar to our observations with mCh-ATG13. Again, productive events predominated (\>70% of total events) in neurons from young adult mice, while stalled events predominated (\~80% of total events) in neurons from aged mice ([Figure 3I--J](#fig3){ref-type="fig"}). While these stalled events did not go on to produce GFP-LC3B-positive autophagosomes, stalled AVs remained dynamic within the confines of the axon tip rather than remaining tethered in place ([Figure 3B and G](#fig3){ref-type="fig"}, [Video 2](#video2){ref-type="video"},[4](#video4){ref-type="video"}). Furthermore, both stalled and productive AVs could be found within the same axonal tip in neurons from both young adult and aged mice ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Videos 5](#video5){ref-type="video"} and [6](#video6){ref-type="video"}). These data suggest that aging does not impair the initial steps of autophagosome biogenesis. However, there is a striking block in LC3B recruitment downstream from the recruitment of both ATG13 and ATG5 that occurs infrequently in neurons from young adult mice, but predominates in neurons from aged mice.

###### Productive biogenesis events in a neuron from an aged mouse.

GFP-LC3B, mCh-ATG5, and SNAP-ATG9 in the distal neurite of a DRG neuron from an aged mouse depicting a productive autophagosome biogenesis event. In the merge movie (bottom), yellow arrowheads denote colocalization of ATG5 and LC3B without ATG9; green arrowheads denote a LC3B-positive punctum from which ATG5 has dissociated. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 3F](#fig3){ref-type="fig"}.

10.7554/eLife.44219.008

###### Stalled biogenesis events in a neuron from an aged mouse.

GFP-LC3B, mCh-ATG5, and SNAP-ATG9 in the distal neurite of a DRG neuron from an aged mouse depicting a stalled autophagosome biogenesis event. In the merge movie (bottom), magenta arrowheads denote colocalization between ATG5 and ATG9 without LC3B. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 3G](#fig3){ref-type="fig"}.

10.7554/eLife.44219.009

###### Productive and stalled biogenesis events occur in the same neuron from a young adult mouse.

GFP-LC3B, mCh-ATG13, and SNAP-ATG9 in the distal neurite of a DRG neuron from a young adult mouse depicting both productive (solid arrowhead, solid arrow) and stalled (outlined arrowhead) autophagosome biogenesis events. In the merge movie (bottom), arrowhead color denotes colocalization state of indicated punctum. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}.

10.7554/eLife.44219.010

###### Productive and stalled biogenesis events occur in the same neuron from an aged mouse.

GFP-LC3B and mCh-ATG5 in the distal neurite of a DRG neuron from an aged mouse depicting both productive (solid arrowhead) and stalled (outlined arrowhead) autophagosome biogenesis events. In the merge movie (bottom), arrowhead color denotes colocalization state of indicated punctum. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}.

10.7554/eLife.44219.011

![Stalled AVs predominate in neurons from aged mice.\
(**A--B**) Time series of merge micrographs of mCh-ATG13 and GFP-LC3B from live cell imaging of the distal neurite of DRGs from aged mice depicting a productive (**A**) or a stalled (**B**) autophagosome biogenesis event. Yellow arrowheads denote colocalization of mCh-ATG13 and GFP-LC3B; green arrowheads denote a GFP-LC3B-positive punctum from which mCh-ATG13 has dissociated; red arrowheads denote mCh-ATG13-positive puncta that fail to recruit GFP-LC3B; solid arrowheads track one punctum, hollow arrowheads follow a second punctum. Magnified views of denoted puncta are shown below full micrograph; border color represents channel or colocalization state in merge. Retrograde is to the right. Scale bars, 2 μm. (**C--D**) Individual intensity profiles were averaged to improve signal-to-noise of mCh-ATG13 (red) and GFP-LC3B (green) for productive (**C**) and stalled (**D**) AVs (mean ± SEM; n ≥ 5 biogenesis events from five neurons from three biological replicates). (**E**) Quantification of the proportion of total mCh-ATG13-positive AV biogenesis events (both productive and stalled events) in DRG neurons from young adult (light gray) and aged (dark gray) mice (mean ± 95% confidence interval; n ≥ 62 AVs from three biological replicates for each condition). \*\*\*\*p\<0.0001 by Fisher's exact test. (**F--G**) Time series of merge micrographs of mCh-ATG5 and GFP-LC3B in the distal neurite of DRGs from aged mice depicting a productive (**F**) or stalled (**G**) autophagosome biogenesis event. Arrowheads point to puncta magnified below micrograph; colors denote channel or colocalization state in merge. Scale bars, 2 μm. (**H--J**) Mean intensity profiles of mCh-ATG5 (red) and GFP-LC3B (green) for productive (**H**) and stalled (**I**) AVs (mean ± SEM; n = 5 productive biogenesis events from five neurons or n = 4 stalled biogenesis events from four neurons from three biological replicates). Vertical dashed line in (**C and H**) indicates the half-maximum of GFP-LC3B intensity, which was used to align the traces. (**J**) Quantification of the proportion of total mCh-ATG5-positive AV biogenesis events (both productive and stalled events) in DRG neurons from young adult and aged mice (mean ± 95% confidence interval; n ≥ 62 AVs from three biological replicates for each condition). \*\*\*\*p\<0.0001 by Fisher's exact test. See also [Videos 1](#video1){ref-type="video"}--[6](#video6){ref-type="video"}.](elife-44219-fig3){#fig3}

Stalled AVs recruit autophagosome biogenesis components {#s2-4}
-------------------------------------------------------

To further characterize stalled events in neurons from aged mice, we asked if other autophagy components colocalize with stalled AVs. ATG9 is the only multi-pass transmembrane protein in the core autophagy machinery ([@bib36]; [@bib58]; [@bib105]) and is thought to transit to the growing isolation membrane with donor membranes ([@bib75]; [@bib83]; [@bib101]; [@bib105]). Normally, ATG9 is only transiently associated with the developing autophagosome ([@bib32]; [@bib60]). We used multi-color live-cell imaging to assess colocalization between autophagy components in neurons from young adult or aged mice co-expressing fluorescently labeled LC3B, ATG9, and ATG13 or ATG5 ([Figure 4A](#fig4){ref-type="fig"}). As expected, we did not observe significant colocalization of SNAP-ATG9 with productive autophagosome biogenesis events in neurons from either young or aged mice ([Figure 4B and D](#fig4){ref-type="fig"}). However, we did observe the robust and persistent colocalization of SNAP-ATG9 with mCh-ATG13 or mCh-ATG5 in the majority of stalled events in neurons from aged mice ([Figure 4A,C and D](#fig4){ref-type="fig"}, [Video 4](#video4){ref-type="video"},[7](#video7){ref-type="video"}). Further, we noted persistent SNAP-ATG9 colocalization with the very rare stalled events seen in neurons from young adult mice ([Figure 4D](#fig4){ref-type="fig"}). These data suggest that ATG9 may only transiently associate with productive biogenesis events, whereas the majority of stalled AVs aberrantly accumulate or retain ATG9.

###### Atg9 accumulates at stalled biogenesis events in a neuron from an aged mouse.

GFP-LC3B, mCh-ATG13, and SNAP-ATG9 in the distal neurite of a DRG neuron from an aged mouse depicting a stalled autophagosome biogenesis event. In the merge movie (bottom), arrowhead color denotes colocalization state of the punctum. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 4A](#fig4){ref-type="fig"}.

10.7554/eLife.44219.014

![Atg9, a multi-pass transmembrane protein, aberrantly associates with stalled AVs in vitro and in vivo.\
(**A**) Time series of live imaging of mCh-ATG13, SNAP-ATG9, and GFP-LC3B in the distal neurite of a DRG neuron from an aged mouse depicting a stalled AV. Magenta arrowheads indicate colocalization between mCh-ATG13 and SNAP-ATG9 without GFP-LC3B. Magnified views of denoted puncta are shown below full micrograph; border color represents channel or colocalization state in merge. Retrograde is to the right. Scale bar, 2 μm. (**B--C**) Mean intensity profiles of mCh-ATG13 (red), SNAP-ATG9 (blue), and GFP-LC3B (green) for productive (**B**) and stalled (**C**) AVs in DRG distal tips from aged mice (mean ± SEM; n = 5 biogenesis events from five neurons from three biological replicates for each graph). Vertical dashed line in (**B**) indicates the half-maximum of GFP-LC3B intensity, which was used to align the traces. (**D**) Quantification of the percentage of AVs that have SNAP-ATG9 associated in the distal neurites of DRGs from young adult and aged mice (mean ± 95% confidence interval; n ≥ 17 for each age group). \*\*\*\*p\<0.0001 by two-tailed Fisher's exact test. (**E--F**) Maximal projection micrographs of NMJs from young adult (three mo) and aged mice (16--17 mo). In panel (**E**), NMJs were stained with α-Bungarotoxin-tetramethylrhodamine (Btx) to stain the endplate, anti-SV2 together with anti-neurofilament H (both in blue) to visualize the presynaptic motor neuron, and anti-LC3B to visualize AVs at the synapse. In panel (**F**), NMJs from young and aged mice were stained with the presynaptic markers SV2 and neurofilmament H (together in blue), as well as antibodies to ATG9 (red) and ATG13 (green). Dashed boxes indicate magnified insets; line scans of ATG9 (red) and ATG13 (green) intensities at the indicated puncta are also shown. Scale bars, 10 μm. Arrowheads denote LC3B AVs (**E**) or the colocalization state of ATG13 with ATG9 at AVs (**F**). (**G--I**) Quantification of micrographs of NMJs from young adult (gray) and aged (dark gray) mice stained with Btx, anti-SV2, anti-neurofilament H, anti-ATG13, and anti-ATG9. (**G**) Quantification of stalled AVs, defined as colocalization of ATG13 and ATG9 at puncta, in the NMJ motor axon terminal. (**H**) Quantification of ATG13 puncta that do not have colocalized ATG9 in the NMJ motor axon terminal. (**I**) Quantification of the fraction of stalled AVs out of the total ATG13-positive puncta in the NMJ motor axon terminal. In G-I, mean ± SEM; n ≥ 62 motor axon terminals for each age from three biological replicates. \*\*\*\*p\<0.0001, ns = 0.3443 by Mann-Whitney t tests. See also [Videos 3](#video3){ref-type="video"},[4](#video4){ref-type="video"},[7](#video7){ref-type="video"}.](elife-44219-fig4){#fig4}

We next sought evidence for a similar stalling of autophagosome biogenesis in vivo. As above, we used NMJs to examine AVs in intact tissues. We identified LC3-positive AVs at these synapses in muscle tissue dissected from both young adult and aged mice ([Figure 4E](#fig4){ref-type="fig"}). We used ATG9 colocalization with either ATG13 or ATG5 as a marker for stalled events in fixed tissue. In NMJs from young adult mice, we observed ATG13 puncta within the presynaptic compartment, but those puncta did not colocalize with ATG9 ([Figure 4F](#fig4){ref-type="fig"}, left). In contrast, in NMJs from aged mice, we observed the colocalization of ATG13 with ATG9, indicating the persistence of stalled AV formation within the presynaptic compartment in vivo ([Figure 4F](#fig4){ref-type="fig"}, right). We then quantified the number of stalled AVs in the NMJ motor axon terminal. While we observed stalled AVs (using ATG9 colocalization with ATG13 as a stalled AV marker) only rarely in motor axon terminals from young adult mice, NMJ axon terminals from aged mice consistently contained several stalled AVs ([Figure 4G](#fig4){ref-type="fig"}). In contrast, we did not detect a change with age in the number of ATG13-positive puncta that did not co-recruit ATG9 ([Figure 4H](#fig4){ref-type="fig"}). Thus, the fraction of stalled AVs to total ATG13-positive puncta significantly increased with age ([Figure 4I](#fig4){ref-type="fig"}). These data suggest that our observations of stalled events in cultured primary DRG neurons from aged mice can also be seen in other neuronal types in vivo.

Since LC3B is not recruited to stalled AVs, we asked whether this defect was due to a failure to recruit the elongation stage constituents required for LC3B lipidation. Using multi-color immunocytochemistry, we examined the localization of endogenous elongation stage components ATG12, ATG7, ATG16L1, and ATG3. We used colocalization of endogenous ATG9 with ATG5 to identify stalled AVs in fixed neurons from aged mice. We observed that the lipidation machinery was successfully recruited to stalled AVs ([Figure 5A--E](#fig5){ref-type="fig"}).

![Recruitment of autophagy machinery, including LC3B homologs, to stalled AVs is not sufficient to rescue the biogenesis defect.\
(**A--E**) Representative maximal projection micrographs of the distal neurites of fixed DRG neurons from aged mice. Stalled AVs are identified by colocalization of anti-ATG5 (green) and anti-ATG9 (blue). Antibodies to other autophagy components are visualized in red: ATG13 (**A**) or elongation complex components ATG12 (**B**), ATG7 (**C**), ATG16L1 (**D**), and ATG3 (**E**). Arrowheads denote colocalization state of AVs (stalled, filled arrowheads). Borders of magnifications of indicated puncta denote channel or colocalization state in merge. (**F--I**) Time series (channels merged) of Halo-ATG5, mAtg8s (mCh-GABARAP in F, mCh-GABARAPL2/GATE16 in G, mCh-GABARAPL1/GEC1 in H, and mScarlet-LC3A in I), and GFP-LC3B in the distal neurite of DRG neurons from aged mice depicting stalled AVs. Arrowheads denote colocalization of mAtg8s with stalled AVs. Magnified views of denoted puncta are shown below full micrograph; border color represents channel or colocalization state in merge. Time is indicated as time since stalled AV was first visible. (**J**) Quantification of the fraction of stalled AVs co-recruiting each LC3/GABARAP family member when individually overexpressed in DRGs from aged mice (mean ± SEM; n ≥ 10 stalled AVs in three biological replicates for each mAtg8). \*\*\*p\<0.001; \*\*\*\*p\<0.0001 by two-tailed Fisher's exact test. Scale bars, 2 μm.](elife-44219-fig5){#fig5}

Given the lack of LC3B recruitment to stalled AVs harboring intact lipidation machinery, we asked whether other LC3B homologs could be recruited to stalled AVs in aged mice. There are multiple orthologs of yeast Atg8 expressed in mammals (mAtg8s), including LC3A, LC3B, LC3C, γ-aminobutyric acid receptor-associated protein (GABARAP), GABARAP-Like 1 (GABARAPL1/GEC1), and GABARAPL2/GATE16 ([@bib73]). Mice do not appear to have a gene encoding LC3C, but may express a LC3 isoform related to human LC3C ([@bib38]). Both immunocytochemistry ([Figure 5---figure supplement 1A--D](#fig5s1){ref-type="fig"}) and live cell imaging ([Figure 5F--I](#fig5){ref-type="fig"}) revealed that LC3A, GABARAP, GABARAPL1/GEC1, and GABARAPL2/GATE16 can each associate with stalled AVs in neurons from aged mice, with each mCherry-mAtg8 colocalizing with persistent Halo-ATG5 puncta ([Figure 5J](#fig5){ref-type="fig"}). These data indicate that the deficit in LC3B recruitment to stalled AVs in neurons from aged mice is specific and that the recruitment of other mAtg8s is not sufficient to convert stalled AVs into productive AVs in neurons from aged mice. These observations are consistent with a growing literature indicating that mAtg8s are not fully functionally redundant ([@bib53]).

Also using live-cell imaging, we asked if ectopic expression of the mAtg8s altered the assembly kinetics of AVs in neurons from aged mice. Surprisingly, we found that overexpression of mScarlet-LC3A, but not other mAtg8s, caused GFP-LC3B recruitment to 84.2% of stalled AVs (persistent Halo-ATG5 puncta), significantly different from control neurons ([Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}; p=0.0002; 21.1% of stalled AVs in control). However, this induced recruitment of GFP-LC3B to stalled AVs did not resolve the stalled event (data not shown), further implying that while the failure to recruit LC3B is a hallmark of stalled AV events, it is not the principal defect involved.

Overexpression of WIPI2 restores the rate of autophagosome biogenesis in neurons from aged mice {#s2-5}
-----------------------------------------------------------------------------------------------

PROPPINs (β-propellers that bind phosphoinositides) are essential PI3P effectors in autophagy and are conserved from yeast to humans ([@bib49]; [@bib64]; [@bib65]). In mammals, there are four PROPPINs, termed WD-repeat protein interacting with phosphoinositides (WIPI1 through WIPI4) ([@bib64]; [@bib65]). WIPI1 and WIPI2 are closely related and orthologs of yeast Atg18, while WIPI3 and WIPI4 form a separate paralogous group ([@bib5]; [@bib64]; [@bib65]). WIPI1, the first family member to be identified to have a role in autophagy, is recruited to autophagosomal membranes upon autophagy induction ([@bib17]; [@bib26]; [@bib66]; [@bib65]; [@bib91]). WIPI2 links PI3P production by the autophagy nucleation complex to LC3 interaction with the isolation membrane as WIPI2 binds to both PI3P and ATG16L1 ([Figure 6A](#fig6){ref-type="fig"}) ([@bib12]; [@bib35]; [@bib64]). Thus, we hypothesized that alterations in WIPI2 function may result in lower levels of LC3B recruitment and deleteriously affect productive biogenesis.

![Overexpression of WIPI2B in neurons from aged mice returns autophagosome biogenesis to levels observed in neurons from young adult mice.\
(**A**) Schematic of WIPI1A and WIPI2B proteins, depicting the PI3P-interaction domains (FRRG), the ATG16L1-binding domain in WIPI2B (R108), and the phosphorylation site in WIPI2B (S395). Point mutations to disrupt these interactions are indicated in the relevant domains (FRRG → FTTG, R108 → E, or S395 → E or A). (**B**) Immunoblot of DRG lysates treated with indicated siRNA, collected after 2 days in vitro. Total protein was used as a loading control; normalization factor is indicated below blot as a percentage. (**C**) Quantification of the rate of AV initiation (mCh-ATG5 puncta) in DRG neurons from young adult mice with control or WIPI2 siRNA or WIPI2 siRNA with indicated RNAi-resistant Halo-WIPI2B or SNAP-WIPI1A constructs (mean ± SEM; n ≥ 15 neurons from three biological replicates for each siRNA condition). ns (not significant) p\>0.05 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**D**) Quantification of the rate of AV biogenesis (GFP-LC3B puncta) in DRG neurons from young adult mice with control or WIPI2 siRNA or WIPI2 siRNA with indicated RNAi-resistant Halo-WIPI2B or SNAP-WIPI1A constructs (mean ± SEM; n ≥ 15 neurons from three biological replicates for each siRNA condition). ns p\>0.05; \*\*\*\*p\<0.0001 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**E**) Time series of merged micrographs of GFP-LC3B, mCh-ATG5, and Halo-WIPI2B WT in the distal neurite of a DRG neuron from an aged mouse depicting a productive autophagosome biogenesis event. Arrowheads indicate colocalization state on the isolation membrane; solid arrowhead follows one punctum, while outlined arrowhead indicates a different AV biogenesis event. Magnified views of denoted puncta are shown below full micrograph; border color represents channel or colocalization state in merge. Retrograde is to the right. Scale bar, 2 μm. (**F**) Quantification of the rate of AV initiation (mCh-ATG5 puncta) in DRG neurons from aged mice with or without overexpression of the indicated Halo-WIPI2B construct (mean ± SEM; n ≥ 17 neurons from three biological replicates for each condition). ns p\>0.05 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**G**) Quantification of the rate of AV biogenesis (marked with GFP-LC3B) in DRG neurons from aged mice with or without overexpression of the indicated Halo-WIPI2B construct (mean ± SEM; n ≥ 17 neurons from three biological replicates for each condition). \*\*\*\*p\<0.0001; ns p\>0.05 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**H**) Mean intensity profiles of mCh-ATG5 (red), Halo-WIPI2B WT (blue), and GFP-LC3B (green) for productive AVs (mean ± SEM; n = 6 biogenesis events from five neurons from three biological replicates). Vertical dashed line indicates the half-maximum of GFP-LC3B intensity, which was used to align the traces.](elife-44219-fig6){#fig6}

First we confirmed the importance of WIPI2 in autophagosome biogenesis in primary neurons. Depletion of WIPI2 by RNAi ([Figure 6B](#fig6){ref-type="fig"}) did not alter rates of AV initiation (determined by mCh-ATG5 puncta generation) ([Figure 6C](#fig6){ref-type="fig"}), but led to a significant deficit in autophagosome biogenesis, which was fully restored by expression of an RNAi-resistant human Halo-WIPI2B construct ([Figure 6D](#fig6){ref-type="fig"}). WIPI2 binds PI3P via a conserved FRRG motif ([@bib4]; [@bib13]; [@bib17]; [@bib27]; [@bib33]; [@bib66]; [@bib65]; [@bib97]). This interaction can be abolished by mutating the positively charged arginine residues in the motif to uncharged threonine residues (FTTG) ([Figure 6A](#fig6){ref-type="fig"}) ([@bib12]). Overexpression of Halo-WIPI2B(FTTG) was unable to rescue the deficit, consistent with a key role for phosphoinositide signaling in autophagosome biogenesis ([Figure 6D](#fig6){ref-type="fig"}). WIPI2B also interacts with ATG16L1, an essential component of the LC3 conjugation complex. The interaction between WIPI2B and ATG16L1 can be abrogated by switching a positively charged arginine to a negatively charged glutamate (R108E) in WIPI2B ([@bib12]). Ectopic expression of Halo-WIPI2B(R108E) in WIPI2-depleted neurons from young adult mice did not affect rates of AV initiation but did not rescue the deficit in the rates of formation of GFP-LC3B-positive autophagosomes ([Figure 6C--D](#fig6){ref-type="fig"}). Furthermore, overexpression of the WIPI2 paralog SNAP-WIPI1A was also unable to compensate for the loss of WIPI2 in young adult neurons ([Figure 6D](#fig6){ref-type="fig"}). These data confirm that WIPI2, including its known functional domains, is required in autophagosome biogenesis in DRG neurons.

Next, we ectopically expressed Halo-tagged WIPI2B in neurons from aged mice. Halo-WIPI2B colocalized with the early autophagosome marker mCh-ATG5 in neurons ([Figure 6E](#fig6){ref-type="fig"}, [Video 8](#video8){ref-type="video"}) and did not affect rates of AV initiation ([Figure 6F](#fig6){ref-type="fig"}). Strikingly, ectopic WIPI2B expression increased rates of autophagosome biogenesis in neurons from aged mice from 0.21 AVs per minute to 0.47 AVs per minute ([Figure 6G](#fig6){ref-type="fig"}), a rate similar to that observed in neurons from young adult mice ([Figure 1B](#fig1){ref-type="fig"}). Furthermore, overexpression of WIPI2B did not alter the kinetics of productive AV biogenesis ([Figure 6H](#fig6){ref-type="fig"}). In contrast to wild type WIPI2B, expression of WIPI2B constructs with targeted mutations in either the PI3P or ATG6L1 binding motifs did not restore autophagosome biogenesis in neurons from aged mice ([Figure 6F--G](#fig6){ref-type="fig"}). These data suggest that overexpression of WIPI2B in neurons from aged mice restores autophagosome biogenesis and that this rescue requires both the PI3P-binding and ATG16L1-binding functions of WIPI2B.

###### WIPI2B colocalizes with other autophagy components in a productive event in a neuron from an aged mouse.

GFP-LC3B, mCh-ATG13, and Halo-WIPI2B in the distal neurite of DRGs from aged mice depicting a productive autophagosome biogenesis event. In the merge movie (bottom), arrowhead color denotes colocalization state of the punctum. Retrograde is to the right. Scale bar, 2 μm. Playback at five frames per second. Movie stills are shown in [Figure 6E](#fig6){ref-type="fig"}.

10.7554/eLife.44219.022

WIPI2B phosphorylation is a molecular switch regulating autophagosome biogenesis {#s2-6}
--------------------------------------------------------------------------------

Given that ectopically expressing WIPI2B in neurons from aged mice rescues rates of autophagosome biogenesis, we initially hypothesized that WIPI2 levels decrease in neuronal tissues with age. However, we observed no significant deficits in WIPI2 expression levels at the level of RNA or protein, or those of any of the WIPI family members with age in either whole brain lysates or DRG lysates ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We also observed no significant changes in expression levels of several other autophagy components (ULK1, P-ULK1, ATG14, P-ATG14, Beclin1, ATG3, ATG5, ATG7, ATG10, ATG16L1, LC3B, LC3A, GABARAP, GABARAPL1, GABARAPL2, p62, WIPI3, and WIPI4) with age in whole brain or DRG lysates ([Figure 6---figure supplement 1A and B](#fig6s1){ref-type="fig"}, [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Additionally, using immunocytochemistry on fixed DRG neurons from aged mice, we observed endogenous WIPI1 and WIPI2 localized to stalled AVs ([Figure 5---figure supplement 1F--G](#fig5s1){ref-type="fig"}). These results indicate that the decrease in autophagosome biogenesis with age is not due to an age-related loss of WIPI2 or its paralogs and that endogenous WIPIs can be recruited to stalled AVs in neurons from aged mice.

Next we looked to post-translational modification of WIPI2. WIPI2B is known to be phosphorylated at serine 395 (S413 in WIPI2A) ([@bib25]; [@bib92]), although the mechanistic effects of this phosphorylation have not been fully explored. We used two independent phosphorylation-sensitive antibodies ([Figure 7---figure supplement 1A,C and D](#fig7s1){ref-type="fig"}) to confirm that phosphorylated WIPI2 is found in neuronal tissues ([Figure 7A](#fig7){ref-type="fig"}). Additionally, we confirmed that we could detect phospho-WIPI2 on AVs in DRG distal neurites by immunocytochemistry ([Figure 7B](#fig7){ref-type="fig"}, [Figure 5---figure supplement 1H](#fig5s1){ref-type="fig"}). Our data ([Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}) agreed with a previous report ([@bib92]) that phosphorylation of WIPI2B at serine 395 does not affect its ability to bind to PI3P or Atg16L1. Next, we asked how WIPI2 phosphorylation affects autophagosome biogenesis. We ectopically expressed a RNAi-resistant nonphosphorylatable construct, Halo-WIPI2B(S395A), or a RNAi-resistant phospho-mimetic construct, Halo-WIPI2B(S395E), in WIPI2-depleted neurons from young adult mice. Similar to our previous results, overexpression of Halo-WIPI2B constructs did not affect rates of AV initiation ([Figure 7C](#fig7){ref-type="fig"}). We found that the phospho-dead construct, Halo-WIPI2B(S395A), rescued rates of autophagosome biogenesis similar to the wild type Halo-WIPI2B construct. In contrast, overexpression of the phospho-mimetic construct, Halo-WIPI2B(S395E), did not restore rates of autophagosome biogenesis in WIPI2-depleted neurons from young adult mice ([Figure 7D](#fig7){ref-type="fig"}). When we expressed these constructs in neurons from aged mice, we obtained similar results; the phospho-dead construct, Halo-WIPI2B(S395A), restored the rate of autophagosome biogenesis in neurons from aged mice, while the phospho-mimetic construct, Halo-WIPI2B(S395E), did not ([Figure 7E](#fig7){ref-type="fig"}). We did not detect differences in the levels of overexpression for the different Halo-WIPI2B constructs or changes in overexpression of ectopic Halo-WIPI2B constructs with age ([Figure 7---figure supplement 1E](#fig7s1){ref-type="fig"}). These data suggest that WIPI2 must be dephosphorylated to enable productive AV biogenesis.

![Dynamic WIPI2B phosphorylation in neurons is required for autophagosome biogenesis.\
(**A**) Immunoblot of whole brain or DRG lysates from aged mice demonstrates p-WIPI2 can be detected with two different phospho-WIPI2 antibodies. (**B**) Representative maximal projection immunocytochemistry micrograph of LC3B and phospho-WIPI2 in the distal tip of a DRG neuron from a young adult mouse. Arrowheads indicate colocalization state on the AV; solid arrowhead indicates puncta with both proteins, while outlined arrowhead designates a different AV with no phospho-WIPI2 colocalized with LC3B. Borders of magnifications of indicated puncta denote channel or colocalization state in merge. Scale bar, 2 μm. (**C**) Quantification of the rate of AV initiation (mCh-ATG5 puncta) in DRG neurons from young adult mice with WIPI2 siRNA or WIPI2 siRNA with indicated RNAi-resistant Halo-WIPI2B constructs (mean ± SEM; n ≥ 17 neurons from three biological replicates for each siRNA condition). ns (not significant) p\>0.05 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**D**) Quantification of the rate of AV biogenesis (GFP-LC3B puncta) in DRG neurons from young adult mice with WIPI2 siRNA or WIPI2 siRNA with indicated RNAi-resistant Halo-WIPI2B constructs (mean ± SEM; n ≥ 17 neurons from three biological replicates for each siRNA condition). ns (not significant) p\>0.05; \*\*\*p=0.0001; \*\*\*\*p\<0.0001 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. (**E**) Quantification of the rate of AV biogenesis (marked with GFP-LC3B) in DRG neurons from aged mice with or without overexpression of the indicated Halo-WIPI2B construct (mean ± SEM; n ≥ 23 neurons from three biological replicates for each condition). \*\*\*\*p\<0.0001; ns (not significant) p\>0.05 by Kruskal-Wallis ANOVA test with Dunn's multiple comparisons test. Horizontal dashed line indicates rate of AV biogenesis in neurons from young adult mice. (**F**) Quantification of AV area change with or without recruitment of Halo-WIPI2B(S395E) (mean ± SEM; n ≥ 24 AVs from 14 neurons from three biological replicates). \*\*\*\*p\<0.0001 by Mann-Whitney test. (**G**) Individual AV area profiles were averaged to improve signal-to-noise of GFP-LC3B puncta that were positive (blue) or negative (black) for Halo-WIPI2B(S395E) (mean ± SEM; n ≥ 25 AVs from ≥17 neurons from three biological replicates). (**H**) Time series of merge micrographs of GFP-LC3B, mCh-ATG13, and Halo-WIPI2B(S395A) in the distal neurite of a DRG neuron from an aged mouse. (**I--J**) Time series of merged micrographs of GFP-LC3B, mCh-ATG13, and Halo-WIPI2B(S395E) in the distal neurite of DRG neurons from aged mice depicting AVs that fail to recruit Halo-WIPI2B(S395E) and fail to grow (**I**) and AVs that do recruit Halo-WIPI2B(S395E) and increase in area (**J**) during the imaging window. Arrowheads indicate colocalization state on the isolation membrane; solid arrowhead follows one punctum, while outlined arrowhead indicates a second AV. Magnified views of denoted puncta are shown below full micrograph; border color represents channel or colocalization state in merge. Retrograde is to the right. Scale bars, 2 μm.](elife-44219-fig7){#fig7}

These results led us to hypothesize that levels of phosphorylated WIPI2 increase with age in neuronal tissues. However, just as we saw with total WIPI2 levels, we did not see an overall change in phosphorylated WIPI2 protein with age in either whole brain or DRG lysates ([Figure 6---figure supplement 1C--E](#fig6s1){ref-type="fig"}). These results suggest that WIPI2 may be found in its phosphorylated form throughout the cytosol and only transiently dephosphorylated at the isolation membrane, masking any functional age-related change in WIPI2 phosphorylation in bulk assays. This hypothesis is consistent with our data indicating that stalled and productive AVs occur in the same axonal tip ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Video 6](#video6){ref-type="video"}), suggesting that AV stalling results from a highly localized defect.

To further characterize the role of phosphorylated WIPI2B in autophagosome biogenesis, we examined AV events in neurons from aged mice overexpressing the phospho-dead construct, Halo-WIPI2b(S395A) or the phospho-mimetic construct, Halo-WIPI2B(S395E) in conjunction with GFP-LC3B and mCh-ATG13, by live-cell microscopy. The phospho-dead construct Halo-WIPI2B(S395A) was cytoplasmic, but also colocalized with mCh-ATG13 and GFP-LC3B on productive AVs ([Figure 7H](#fig7){ref-type="fig"}). Next, we examined neurons from aged mice ectopically expressing the phospho-mimetic Halo-WIPI2B(S395E) construct. We identified GFP-LC3B-positive AVs and determined whether WIPI2B(S395E) was ever associated with the AV during the video. GFP-LC3B-positive AV events that failed to recruit Halo-WIPI2B(S395E) did not increase in size ([Figure 7F,G and I](#fig7){ref-type="fig"}, [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}), suggesting that the isolation membrane could not successfully extend. In contrast, GFP-LC3B-positive AV events that did recruit Halo-WIPI2B(S395E) increased in size to form a GFP-LC3B ring structure, consistent with a mature autophagosome ([Figure 7F,G and J](#fig7){ref-type="fig"}). Taken together, these results suggest that WIPI2B is dephosphorylated at the isolation membrane to allow autophagosome biogenesis to initiate. Further, these results suggest that WIPI2B is then dynamically rephosphorylated at the AV to enable the autophagosome to grow and complete biogenesis.

If this hypothesis is correct, phosphorylation of WIPI2B at serine 395 might affect its affinity for membranes. To determine whether the phosphorylation state of WIPI2B affects its ability to interact with membranes, we performed crude fractionation experiments. We collected whole brain lysates from young adult and aged nontransgenic mice and separated the cytosolic and membrane fractions by centrifugation. We then compared the endogenous levels of phospho-WIPI2 and total WIPI2 associated with each fraction by immunoblot ([Figure 8A](#fig8){ref-type="fig"}). The ratio between phospho-WIPI2 and total WIPI2 in the membrane fraction was reduced by approximately 50% compared to the cytosolic fraction for both ages ([Figure 8B](#fig8){ref-type="fig"}). These results suggest that phosphorylation of WIPI2B at serine 395 decreases its affinity for membranes.

![Phosphorylation of WIPI2B at serine 395 decreases the affinity of WIPI2B for membranes.\
(**A**) Immunoblot of cytosolic and membrane fractions of brain lysates from young adult (left) and aged (right) mice (n = 4 biological replicates for each age). (**B**) Quantification of the ratio of Phospho-WIPI2 to total WIPI2 in the cytosolic (cyto) and membrane (mem) fractions from the immunoblot in A (mean ± SEM; n = 4 biological replicates for each age). \*\*\*\*p\<0.0001; \*\*\*p=0.0001 by two-tailed unpaired t test. (**C**) Quantification of the residence time of Halo-WIPI2B(S395A) or SNAP-WIPI2B(S395E) in the distal tips of DRG neurons from young adult mice with WIPI2 siRNA (mean ± SEM; n = 25 neurons from three biological replicates). \*\*\*\*p\<0.0001 by Mann-Whitney test. (**D**) Time series of merged micrographs of GFP-LC3B, mCh-ATG5, and Halo-WIPI2B(S395E) in the distal neurite of a DRG neuron from an aged mouse depicting an AV that fails to recruit Halo-WIPI2B(S395E) and fails to grow (open arrowhead) and an AV that does recruit Halo-WIPI2B(S395E) and increases in area (filled arrowhead) during the imaging window in the same DRG distal neurite. Arrowheads indicate colocalization state on the isolation membrane. Magnified views of denoted puncta are shown below full micrograph; border color represents channel or colocalization state in merge. Retrograde is to the right. Scale bar, 2 μm.](elife-44219-fig8){#fig8}

We also tested our hypothesis that phosphorylation of WIPI2B at serine 395 causes WIPI2B to disassociate from the AV membrane in live-cell imaging of both the phospho-dead WIPI2B(S395A) and phospho-mimetic WIPI2B(S395E) constructs in the same neurons. We examined the dynamics of ectopically expressed RNAi-resistant Halo-WIPI2B(S395A) and SNAP-WIPI2B(S395E) in WIPI2-depleted DRG neurons from young adult mice. We measured the length of time each WIPI2B construct resided at a given punctum. Since our time-lapse videos were captured over 10 min, the maximum residence time we could measure was 600 s. We found that Halo-WIPI2B(S395A) remained associated for nearly 600 s on average. In contrast, in the same neurons, SNAP-WIPI2B(S395E) only remained associated with puncta for approximately 300 s, or half as long as the phospho-dead construct ([Figure 8C](#fig8){ref-type="fig"}). These data are consistent with our lysate fractionation data, indicating that phosphorylation of WIPI2B at serine 395 correlates with a decreased affinity for membranes.

Similar to our observations of other aspects of AV biogenesis, within a given DRG axonal tip, we could observe both an expanding AV that co-recruited Halo-WIPI2B(S395E) and an AV that was Halo-WIPI2B(S395E)-negative that failed to enlarge ([Figure 8D](#fig8){ref-type="fig"}). Thus, the rephosphorylation of WIPI2B(S395) may also be a highly localized process. The dynamic phosphorylation of WIPI2 during AV biogenesis at the isolation membrane could allow for tight, spatially and temporally localized regulation of autophagy ([Figure 9](#fig9){ref-type="fig"}).

![Local dynamic phosphorylation of WIPI2B is required for progression through autophagosome biogenesis.\
Model of how dynamic phosphorylation of WIPI2 and autophagosome biogenesis changes in neurons with aging, characterized by formation of both productive and stalled events.](elife-44219-fig9){#fig9}

Discussion {#s3}
==========

Here, we investigated the dynamics of autophagy during aging in primary neurons and demonstrated that the rate of autophagosome biogenesis significantly decreases in neurons with age. Surprisingly, the deficit was specific, as the initial stages of autophagosome formation, initiation and nucleation, were not altered with age in mammalian neurons. Instead, we found that the majority of AVs in aged neurons successfully initiated but then stalled. EM analysis suggested that this deficit was correlated with a morphological defect in autophagosome formation, characterized by excess membrane accumulation within the autophagic vacuole, detectable in aged neurons both in vitro and in vivo. WIPI2B overexpression in neurons from aged mice increased the rate of autophagosome biogenesis, restoring this rate to that found in neurons from young adult mice. Further, we propose that the dynamic regulation of WIPI2B phosphorylation at the isolation membrane may be integral to autophagosome biogenesis. Our results indicated that the nonphosphorylatable S395A form of WIPI2B was sufficient to rescue AV biogenesis upon depletion of endogenous WIPI2, while recruitment of the phosphomimetic WIPI2B(S395E) mutant correlated with expansion of the nascent autophagosome, suggesting that both dephosphorylation and rephosphorylation of WIPI2B are key regulatory steps. Ultimately, we showed that the rate of autophagosome biogenesis decreased in neurons during aging, but we mitigated this decrease by overexpressing a single autophagy component, WIPI2B ([Figure 6G](#fig6){ref-type="fig"}).

In neurons from aged mice, the majority of stalled AVs aberrantly accumulated ATG9 ([Figure 4](#fig4){ref-type="fig"}). Our results showing that WIPI2B overexpression in aged neurons restored autophagosome biogenesis are consistent with previous studies indicating that WIPI2 downregulation induced the localized accumulation of ATG9 at AVs ([@bib60]). We hypothesize that the multilamellar structures we detected by TEM ([Figure 1](#fig1){ref-type="fig"}) correlate with the stalled AVs we observed by fluorescence microscopy. Work from other groups suggest that this hypothesis could be correct. ATG9 interacts with ATG2, a conserved core autophagy protein ([@bib3]; [@bib18]; [@bib76]; [@bib93]). ATG2 also interacts with WIPI4 ([@bib5]; [@bib9]; [@bib39]; [@bib90]). The speculation that the ATG2-ATG9 complex transfers lipids to the membrane-hungry growing autophagosome ([@bib18]; [@bib34]) was recently confirmed in yeast ([@bib61]) and mammalian cells ([@bib88]). Thus, the prolonged association of ATG9 with stalled AVs detected in neurons from aged mice ([Figure 4](#fig4){ref-type="fig"}) may indicate a prolonged association of ATG2 with stalled AVs. This extended residency at the AV could enable unregulated lipid transfer to the stalled AV, resulting in the multilamellar structures we observed in neurons from aged mice ([Figure 1](#fig1){ref-type="fig"}).

We also found that stalled AVs failed to recruit LC3B ([Figure 3](#fig3){ref-type="fig"}), while the recruitment of other mAtg8s was not affected ([Figure 5](#fig5){ref-type="fig"}). Of note, lipidation of LC3B is less efficient on less curved and less PE-rich membranes than lipidation of GABARAPL1 ([@bib51]), suggesting that stalled AVs contain sufficient curvature and have a sufficient PE concentration to allow the lipidation and incorporation of all mAtg8s except LC3B. Furthermore, inducing the recruitment of LC3B to AVs by LC3A overexpression was not sufficient to rescue autophagosome formation. These results, in conjunction with recent observations ([@bib53]; [@bib86]), suggest that LC3B recruitment is neither strictly required nor sufficient for AV generation and elongation. Instead, LC3B recruitment may regulate membrane expansion or membrane fusion to form a double-membrane structure. We propose that upon perturbation of dynamic WIPI2 phosphorylation, membrane extension may proceed in an unrestricted manner, generating the multilamellar structures observed by TEM in neurons from aged mice ([Figure 1](#fig1){ref-type="fig"}) ([@bib45]) and in aged human AD brain ([@bib55]). Here, we chose to focus on WIPI2 as a master regulator of autophagosome biogenesis. However, it will be interesting to determine in the future how LC3B incorporation into the isolation membrane relates to lipid incorporation and autophagosome membrane extension and expansion.

The autophagy pathway has been extensively studied in non-neuronal cells, where autophagy can be induced by starvation or other cellular stressors ([@bib1]; [@bib21]; [@bib46]; [@bib69]; [@bib77]; [@bib99]; [@bib107]). Conversely, in vivo and in vitro studies in neurons indicate that neuronal autophagy is not significantly induced by starvation ([@bib15]; [@bib42]; [@bib50]; [@bib87]) or by proteotoxic stress ([@bib40]; [@bib98]). These studies suggest that autophagosome biogenesis is regulated differentially in neuronal and non-neuronal cells. Our results indicate that induction of autophagosome biogenesis is constitutive and remains robust during aging in neurons ([Figure 2](#fig2){ref-type="fig"}). Further, our data identify a novel age-related regulation of neuronal autophagosome biogenesis, suggesting that autophagy can be regulated at distinct steps apart from the autophagy initiation complex. Consistent with our finding that WIPI2 regulates basal autophagy, WIPI1 and WIPI2 recruitment to AVs is independent of glucose starvation ([@bib47]; [@bib63]). Our data ultimately suggest that neuronal autophagy may be more easily modulated ectopically via WIPI2B than the better-studied, starvation-sensitive ULK1-ATG13 initiation complex.

Stalled AVs in neurons from aged mice provide a unique opportunity to tease apart the role of WIPI2B in autophagosome biogenesis. WIPI2 interacts with PI3P at the isolation membrane and is required for subsequent WIPI1 localization ([@bib2]). Both WIPI1 and WIPI2 are predicted to form an amphipathic α-helix upon lipid binding, similar to the yeast homolog, Atg18 ([@bib19]), which can promote membrane deformation. Further, Atg18 forms oligomers upon membrane binding ([@bib19]; [@bib72]). Considering our data in conjugation with these data from cell lines, we now propose that WIPI2 dephosphorylation at S395 may allow robust recruitment of WIPI2 and WIPI1 to the isolation membrane. The recruitment of WIPI1 and formation of WIPI1-WIPI2 hetero-oligomers promote membrane deformation. Of note, dephosphorylation of yeast Atg18 is required for Atg18 association with the membrane ([@bib84]), suggesting that the dynamic phosphorylation of PROPPINs could be a conserved regulatory mechanism for autophagy.

Further support for a sequential phosphorylation model would come from the identification of the kinase(s) responsible for WIPI2(S395) phosphorylation. One WIPI2 kinase, mTORC1, has recently been identified ([@bib25]; [@bib92]). While this study found that phosphorylated WIPI2B led to its degradation by the proteasome in HEK293T cells, our data indicate a more nuanced role for phosphorylated WIPI2 in autophagosome biogenesis in neurons. Our results indicated that phosphorylation at WIPI2B serine 395 lowered the affinity of WIPI2B for membrane and shortened the residence time at the nascent autophagic membrane ([Figure 8A--C](#fig8){ref-type="fig"}). Recruitment of WIPI2B(S395E) to the isolation membrane correlated with expansion of the autophagosome membrane ([Figure 7F--J](#fig7){ref-type="fig"}), so we speculate that dissociation of WIPI2B might be a critical and regulated step during autophagosome biogenesis ([Figure 9](#fig9){ref-type="fig"}). Thus, it will be interesting to determine how a specific post-translational modification could have such opposite effects on the same pathway.

We also propose that a localized phosphatase may regulate WIPI2 activity at the developing autophagosome. One compelling candidate is PP2A, which has been implicated in autophagy regulation ([@bib43]; [@bib52]; [@bib104]) and shown to interact with WIPI2 via a PP2A regulatory subunit, PPP2R1A ([@bib2]). An age-related decrease in phosphatase levels in neural tissues has been implicated in Alzheimer's disease ([@bib78]), and PP2A has been shown to decrease in neural tissues with age ([@bib89]), suggesting that declining PP2A activity could contribute to the defect we observed.

Our data suggest that successful autophagosome biogenesis is dependent on the localized environment surrounding the isolation membrane. We observed that a given DRG distal tip could contain both productive and stalled events ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We also detected WIPI2B(S395E)-positive and --negative AVs within a given DRG axonal tip ([Figure 8D](#fig8){ref-type="fig"}). Since the rate of AV biogenesis decreased with age in neurons ([Figure 1](#fig1){ref-type="fig"}), at least one component critical to the process is likely altered during aging. However, we now propose that rather than a change in protein level, the critical component might become mislocalized during aging. This age-related mislocalization would prevent an isolation membrane from developing into a productive autophagosome, explaining the observed decreased rate of AV biogenesis with age.

In this study, we focused on the effects of aging on neuronal autophagosome biogenesis. However, there are critical steps in the autophagy pathway downstream from initial autophagosome biogenesis, including autophagosome closure, fusion with lysosomes, retrograde transport of autophagosomes and autolysosomes to the soma, and degradation of cargo. Aging also likely affects these later stages of autophagy. For example, lysosomal integrity has been shown to decrease with age in neurons ([@bib57]). In non-neuronal cells, retrograde transport of autophagosomes appears to decrease with age in primary mouse fibroblasts ([@bib6]). It will be interesting to investigate how the later stages of autophagy are altered with age in neurons.

Misregulation of autophagy has been implicated in many neurodegenerative diseases and disorders ([@bib20]; [@bib31]; [@bib30]; [@bib55]; [@bib71]). While ectopic induction of autophagy has met with some success in attenuating aggregated mutant huntingtin and Tau in neurodegeneration models ([@bib67]; [@bib95]), our data suggest that targeting the autophagy initiation complex may not be generally effective for treatment of age-related neurodegenerative disease. Rather, modulating other stages of autophagosome biogenesis, such as dynamic WIPI2 phosphorylation at the isolation membrane, may produce more successful therapies.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                           Designation                                                 Source or\                                                                                          Identifiers                                                                             Additional\
  (species) or\                                                                                       reference                                                                                                                                                                                   information
  resource                                                                                                                                                                                                                                                                                        
  --------------------------------------- ----------------------------------------------------------- --------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------
  Genetic reagent (*Mus musculus*)        GFP-LC3B                                                    RIKEN BioResource Center in Japan; PMID: [14699058](https://www.ncbi.nlm.nih.gov/pubmed/14699058)   RRID:[IMSR_RBRC00806](https://scicrunch.org/resolver/IMSR_RBRC00806)                    

  Genetic reagent (*M. musculus*)         C57BL/6J                                                    Jackson Laboratory                                                                                  Cat \# 000664; RRID:[IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)   

  Cell line (*Homo sapiens*)              HEK293                                                      Gibco (ThermoFisher)                                                                                Cat \# R70507                                                                           Authenticated by STR profiling; tested negative for mycoplasma

  Cell line (*H. sapiens*)                HeLa-M                                                      A. Peden (Cambridge Institute for Medical Research)                                                                                                                                         Authenticated by STR profiling; tested negative for mycoplasma

  Transfected construct (*H. sapiens*)    mCherry-ATG13                                               This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_22875](https://scicrunch.org/resolver/Addgene_22875)

  Transfected construct (*M. musculus*)   mCherry-ATG5                                                Addgene; PMID:[16645637](https://www.ncbi.nlm.nih.gov/pubmed/16645637)                              RRID:[Addgene_13095](https://scicrunch.org/resolver/Addgene_13095)                      

  Transfected construct (*H. sapiens*)    Halo-ATG5                                                   This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_13095](https://scicrunch.org/resolver/Addgene_13095)

  Transfected construct (*H. sapiens*)    SNAP-ATG9                                                   This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_60609](https://scicrunch.org/resolver/Addgene_60609)

  Transfected construct (*H. sapiens*)    Halo-ATG9                                                   This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_60609](https://scicrunch.org/resolver/Addgene_60609)

  Transfected construct (*H. sapiens*)    SNAP-WIPI1A                                                 This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_38272](https://scicrunch.org/resolver/Addgene_38272)

  Transfected construct (*M. musculus*)   Halo-DFCP1                                                  This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_38269](https://scicrunch.org/resolver/Addgene_38269)

  Transfected construct (*H. sapiens*)    mScarlet-LC3A                                               This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_73946](https://scicrunch.org/resolver/Addgene_73946)

  Transfected construct (*H. sapiens*)    mCherry-GABARAP                                             This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_73948](https://scicrunch.org/resolver/Addgene_73948)

  Transfected construct (*H. sapiens*)    mCherry-GEC1(GABARAPL1)                                     This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_73945](https://scicrunch.org/resolver/Addgene_73945)

  Transfected construct (*H. sapiens*)    mCherry-GATE16(GABARAPL2)                                   This paper                                                                                                                                                                                  Subcloned from RRID:[Addgene_73518](https://scicrunch.org/resolver/Addgene_73518)

  Transfected construct (*H. sapiens*)    SNAP-WIPI2B WT                                              This paper                                                                                                                                                                                  Subcloned from GFP-WIPI2B, PMID: [24954904](https://www.ncbi.nlm.nih.gov/pubmed/24954904)

  Transfected construct (*H. sapiens*)    Halo-WIPI2B WT                                              This paper                                                                                                                                                                                  Subcloned from GFP-WIPI2B, PMID: [24954904](https://www.ncbi.nlm.nih.gov/pubmed/24954904)

  Transfected construct (*H. sapiens*)    SNAP-WIPI2B (FTTG)                                          This paper                                                                                                                                                                                  Generated via quick change from SNAP-WIPI2B WT

  Transfected construct (*H. sapiens*)    Halo-WIPI2B (FTTG)                                          This paper                                                                                                                                                                                  Generated via quick change from Halo-WIPI2B WT

  Transfected construct (*H. sapiens*)    SNAP-WIPI2B (R108E)                                         This paper                                                                                                                                                                                  Generated via quick change from SNAP-WIPI2B WT

  Transfected construct (*H. sapiens*)    Halo-WIPI2B (R108E)                                         This paper                                                                                                                                                                                  Generated via quick change from Halo-WIPI2B WT

  Transfected construct (*H. sapiens*)    SNAP-WIPI2B (S395A)                                         This paper                                                                                                                                                                                  Generated via quick change\
                                                                                                                                                                                                                                                                                                  from SNAP-WIPI2B WT

  Transfected construct (*H. sapiens*)    Halo-WIPI2B (S395A)                                         This paper                                                                                                                                                                                  Generated via quick change from Halo-WIPI2B WT

  Transfected construct (*H. sapiens*)    SNAP-WIPI2B (S395E)                                         This paper                                                                                                                                                                                  Generated via quick change\
                                                                                                                                                                                                                                                                                                  from SNAP-WIPI2B WT

  Transfected construct (*H. sapiens*)    Halo-WIPI2B (S395E)                                         This paper                                                                                                                                                                                  Generated via quick change from Halo-WIPI2B WT

  Antibody                                Anti-Actin, Mouse Polyclonal                                EMD Millipore                                                                                       Cat \# MAB1501; RRID:[AB_2223041](https://scicrunch.org/resolver/AB_2223041)            WB (1:3000)

  Antibody                                Anti-ATG10, Rabbit Polyclonal                               Novus                                                                                               Cat \# NBP2-38524                                                                       WB (1:100)

  Antibody                                Anti-ATG12, Rabbit Polyclonal                               Abcam                                                                                               Cat \# ab155589                                                                         ICC (1:50)

  Antibody                                Anti-ATG13, Rabbit Polyclonal                               Abcam                                                                                               Cat \# ab105392; RRID:[AB_10892365](https://scicrunch.org/resolver/AB_10892365)         ICC (1:50), IHC (1:100)

  Antibody                                Anti-ATG14, Rabbit Monoclonal                               Cell Signaling Technology                                                                           Cat \# 96752; RRID:[AB_2737056](https://scicrunch.org/resolver/AB_2737056)              WB (1:1000)

  Antibody                                Anti-ATG16L1, Rabbit Monoclonal                             Abcam                                                                                               Cat \# ab187671                                                                         WB (1:1000), ICC (1:50)

  Antibody                                Anti-ATG3, Rabbit Monoclonal                                Abcam                                                                                               Cat \# ab108251; RRID:[AB_10865145](https://scicrunch.org/resolver/AB_10865145)         WB (1:3000), ICC (1:50)

  Antibody                                Anti-ATG5, Rabbit Monoclonal                                Abcam                                                                                               Cat \# ab108327; RRID:[AB_2650499](https://scicrunch.org/resolver/AB_2650499)           WB (1:1000)

  Antibody                                Anti-ATG5-Alexa647, Rabbit Monoclonal                       Abcam                                                                                               Cat \# ab206715                                                                         ICC (1:50 ON)

  Antibody                                Anti-ATG7, Rabbit Monoclonal                                Abcam                                                                                               Cat \# ab133528; RRID:[AB_2532126](https://scicrunch.org/resolver/AB_2532126)           WB (1:1000), ICC (1:50)

  Antibody                                Anti-ATG9, Armenian Hamster Monoclonal                      Abcam                                                                                               Cat \# ab187823                                                                         ICC (1:100), IHC (1:100)

  Antibody                                Anti-ATG9-Alexa488, Rabbit Monoclonal                       Abcam                                                                                               Cat \# ab206252                                                                         ICC (1:50 ON)

  Antibody                                Anti-Beclin1 (BECN1), Mouse Monoclonal                      Santa Cruz                                                                                          Cat \# sc-48341; RRID:[AB_626745](https://scicrunch.org/resolver/AB_626745)             WB (1:200)

  Antibody                                Anti-GABARAP, Rabbit Monoclonal                             Cell Signaling Technology                                                                           Cat \# 13733; RRID:[AB_2798306](https://scicrunch.org/resolver/AB_2798306)              WB (1:1000), ICC (1:50)

  Antibody                                Anti-GAPDH, Mouse Monoclonal                                Abcam                                                                                               Cat \# ab9484; RRID:[AB_307274](https://scicrunch.org/resolver/AB_307274)               WB (1:1000)

  Antibody                                Anti-GABARAPL1 (GEC1), Rabbit Monoclonal                    Cell Signaling Technology                                                                           Cat \# 26632; RRID:[AB_2798928](https://scicrunch.org/resolver/AB_2798928)              WB (1:1000), ICC (1:200)

  Antibody                                Anti-GABARAPL2 (GATE16), Rabbit Polyclonal                  Abcam                                                                                               Cat \# ab137511                                                                         ICC (1:50)

  Antibody                                Anti-GABARAPL2 (GATE16), Rabbit Monoclonal                  Cell Signaling Technology                                                                           Cat \# 14256; RRID:[AB_2798436](https://scicrunch.org/resolver/AB_2798436)              WB (1:1000)

  Antibody                                Anti-GABARAPs, Rabbit Monoclonal                            Abcam                                                                                               Cat \# ab109364; RRID:[AB_10861928](https://scicrunch.org/resolver/AB_10861928)         ICC (1:100)

  Antibody                                Anti-Halo, Mouse Monoclonal                                 Promega                                                                                             Cat \# G9211                                                                            WB (1:500), IP (3 μg)

  Antibody                                Anti-HSP90, Rabbit Monoclonal                               Cell Signaling Technology                                                                           Cat \# 4877; RRID:[AB_2233307](https://scicrunch.org/resolver/AB_2233307)               WB (1:1000)

  Antibody                                Anti-LC3, Rabbit Polyclonal                                 Abcam                                                                                               Cat \# ab48394; RRID:[AB_881433](https://scicrunch.org/resolver/AB_881433)              IHC (1:200)

  Antibody                                Anti-LC3A, Rabbit Monoclonal                                Cell Signaling Technology                                                                           Cat \# 4599; RRID:[AB_10548192](https://scicrunch.org/resolver/AB_10548192)             WB (1:1000)

  Antibody                                Anti-LC3B, Mouse Monoclonal                                 Santa Cruz                                                                                          Cat \# sc-376404; RRID:[AB_11150489](https://scicrunch.org/resolver/AB_11150489)        WB (1:100), ICC (1:50)

  Antibody                                Anti-MEK1/2, Rabbit Monoclonal                              Cell Signaling Technology                                                                           Cat \# 8727; RRID:[AB_10829473](https://scicrunch.org/resolver/AB_10829473)             WB (1:1000)

  Antibody                                Anti-NFH, Chicken Polyclonal                                Aves                                                                                                Cat \# NFH; RRID:[AB_2313552](https://scicrunch.org/resolver/AB_2313552)                IHC (1:400)

  Antibody                                Anti-p62, Mouse Monoclonal                                  Abcam                                                                                               Cat \# ab56416; RRID:[AB_945626](https://scicrunch.org/resolver/AB_945626)              WB (1:200)

  Antibody                                Anti-phospho-ATG14(S29), Rabbit Polyclonal                  Cell Signaling Technology                                                                           Cat \# 13155; RRID:[AB_2798133](https://scicrunch.org/resolver/AB_2798133)              WB (1:1000)

  Antibody                                Anti-phospho-ULK1(S757), Rabbit Polyclonal                  Cell Signaling Technology                                                                           Cat \# 6888; RRID:[AB_10829226](https://scicrunch.org/resolver/AB_10829226)             WB (1:500)

  Antibody                                Anti-phospho-WIPI2(S395), Rabbit Polyclonal                 Cell Signaling Technology                                                                           Cat \# 13571; RRID:[AB_2798259](https://scicrunch.org/resolver/AB_2798259)              WB (1:1000)

  Antibody                                Anti-phospho-WIPI2(S395), Rabbit Polyclonal                 This paper                                                                                          \# STO 316PB2                                                                           WB (1:500), ICC (1:50)

  Antibody                                Anti-SV2, Mouse Monoclonal                                  Developmental Studies Hybridoma Bank, University of Iowa                                            Cat \# SV2; RRID:[AB_2315387](https://scicrunch.org/resolver/AB_2315387)                IHC (1:100)

  Antibody                                Anti-ULK1, Rabbit Monoclonal                                Cell Signaling Technology                                                                           Cat \# 8054; RRID:[AB_11178668](https://scicrunch.org/resolver/AB_11178668)             WB (1:500)

  Antibody                                Anti-V-type H + ATPase, Rabbit Polyclonal                   Synaptic Systems                                                                                    Cat \# 109--002; RRID:[AB_887696](https://scicrunch.org/resolver/AB_887696)             WB (1:500)

  Antibody                                Anti-WIPI1, Rabbit Polyclonal                               ThermoFisher                                                                                        Cat \# PA5-34973; RRID:[AB_2552322](https://scicrunch.org/resolver/AB_2552322)          WB (1:500)

  Antibody                                Anti-WIPI2, Mouse Monoclonal                                Abcam                                                                                               Cat \# ab105459; RRID:[AB_10860881](https://scicrunch.org/resolver/AB_10860881)         WB (1:4000)

  Antibody                                Anti-WIPI3, Mouse IgM Monoclonal                            Santa Cruz                                                                                          Cat \# sc-514194                                                                        WB (1:100)

  Antibody                                Anti-WIPI4, Rabbit Polyclonal                               ThermoFisher                                                                                        Cat \# PA5-71803; RRID:[AB_2717657](https://scicrunch.org/resolver/AB_2717657)          WB (1:250)

  Antibody                                Anti-Chicken IgY-AlexaFluor405, Goat Polyclonal             Abcam                                                                                               Cat \# ab175674                                                                         IHC (1:200)

  Antibody                                Anti-Mouse IgG-AlexaFluor405, Goat Polyclonal               ThermoFisher                                                                                        Cat \# A31553; RRID:[AB_221604](https://scicrunch.org/resolver/AB_221604)               IHC (1:200)

  Antibody                                Anti-Armenian Hamster-AlexaFluor647, Goat Polyclonal        Abcam                                                                                               Cat \# ab173004; RRID:[AB_2732023](https://scicrunch.org/resolver/AB_2732023)           IHC (1:200)

  Antibody                                Anti-Rabbit-AlexaFluor488,Goat Polyclonal                   ThermoFisher                                                                                        Cat \# A11034; RRID:[AB_2576217](https://scicrunch.org/resolver/AB_2576217)             IHC (1:200)

  Antibody                                Anti-Armenian Hamster-AlexaFluor488, Goat Polyclonal        Abcam                                                                                               Cat \# ab173003                                                                         ICC (1:200)

  Antibody                                Anti-Rabbit IgG-AlexaFluor546, Donkey Polyclonal            ThermoFisher                                                                                        Cat \# A10040; RRID:[AB_2534016](https://scicrunch.org/resolver/AB_2534016)             ICC (1:200)

  Antibody                                Anti-Mouse IgG-AlexaFluor546, Donkey Polyclonal             ThermoFisher                                                                                        Cat \# A10036; RRID:[AB_2534012](https://scicrunch.org/resolver/AB_2534012)             ICC (1:200)

  Antibody                                Anti-Rabbit IgG-AlexaFluor647, Donkey Polyclonal            ThermoFisher                                                                                        Cat \# A31573; RRID:[AB_2536183](https://scicrunch.org/resolver/AB_2536183)             ICC (1:200), IHC (1:200)

  Antibody                                Anti-Rabbit IgG-IRDye 800CW, Donkey Polyclonal              LI-COR Biosciences                                                                                  Cat \# 926--32213; RRID:[AB_621848](https://scicrunch.org/resolver/AB_621848)           WB (1:20,000)

  Antibody                                Anti-Mouse IgG-IRDye 800CW, Donkey Polyclonal               LI-COR Biosciences                                                                                  Cat \# 926--32212; RRID:[AB_621847](https://scicrunch.org/resolver/AB_621847)           WB (1:20,000)

  Antibody                                Anti-Mouse IgM-IRDye 800CW, Goat Polyclonal                 LI-COR Biosciences                                                                                  Cat \# 926--32280                                                                       WB (1:20,000)

  Antibody                                Anti-Rabbit IgG-IRDye 680RD, Donkey Polyclonal              LI-COR Biosciences                                                                                  Cat \# 926--68073; RRID:[AB_10954442](https://scicrunch.org/resolver/AB_10954442)       WB (1:10,000)

  Antibody                                Anti-Mouse IgG Light Chain-AlexaFluor680, Goat Polyclonal   Jackson ImmunoResearch Labs                                                                         Cat \# 115-625-174; RRID:[AB_2338937](https://scicrunch.org/resolver/AB_2338937)        WB (1:20,000)

  Sequence-based reagent                  ON-TARGET plus SMARTpool Mouse Wipi2 siRNA                  Dharmacon                                                                                           Cat \# L-057690--01                                                                     Proprietary sequence

  Sequence-based reagent                  ON-TARGET plus non-targeting siRNA                          Dharmacon                                                                                           Cat \# D-001810--01                                                                     Proprietary sequence

  Chemical compound, drug                 SNAP-Cell 647-SiR                                           New England Biolabs                                                                                 Cat \# S9102S                                                                           

  Chemical compound, drug                 SNAP-Cell TMR-Star                                          New England Biolabs                                                                                 Cat \# S9105S                                                                           

  Chemical compound, drug                 SNAP-Cell 430                                               New England Biolabs                                                                                 Cat \# S9109S                                                                           

  Chemical compound, drug                 HaloTag TMR                                                 Promega                                                                                             Cat \# G8251                                                                            

  Chemical compound, drug                 silicon-rhodamine-Halo                                      K. Johnsson, École Polytechnique Federale de Lausanne                                                                                                                                       

  Chemical compound, drug                 JF646-Halo                                                  Luke Lavis, Janelia Farms (HHMI)                                                                                                                                                            

  Chemical compound, drug                 α-Bungarotoxin-tetramethylrhodamine                         Sigma                                                                                               T0195                                                                                   

  Software, algorithm                     Volocity                                                    PerkinElmer                                                                                                                                                                                 

  Software, algorithm                     FIJI                                                        PMID: [22743772](https://www.ncbi.nlm.nih.gov/pubmed/22743772)                                                                                                                              

  Software, algorithm                     Prism 6, Prism 8                                            GraphPad                                                                                                                                                                                    

  Software, algorithm                     Adobe Illustrator CS4                                       Adobe Systems                                                                                                                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Reagents {#s4-1}
--------

GFP-LC3B transgenic mice (strain: B6.Cg-Tg(CAG-EGFP/LC3)53Nmi/NmiRbrc) were generated by N. Mizushima (Tokyo Medical and Dental University, Tokyo, Japan; [@bib50]) and obtained from RIKEN BioResource Center in Japan. These mice were bred with C57BL/6J mice obtained from The Jackson Laboratory. Hemizygous and wild type littermates were used in experiments. Constructs used include: mCherry-ATG13 (subcloned from Addgene 22875), mCherry-ATG5 (Addgene 13095), Halo-ATG5 (subcloned from Addgene 13095), SNAP-ATG9 and Halo-ATG9 (subcloned from Addgene 60609), SNAP-WIPI1A (subcloned from Addgene 38272), Halo-DFCP1 (subcloned from Addgene 38269), mSarlet-LC3A (subcloned from Addgene 73946), mCherry-GABARAP (subcloned from Addgene 73948), mCherry-GEC1 (GABARAPL1, subcloned from Addgene 73945), and mCherry-GATE16 (GABARAPL2, subcloned from Addgene 73518). SNAP-WIPI2B and Halo-WIPI2B were subcloned from GFP-WIPI2B ([@bib12]). SNAP- and Halo- WIPI2B(FTTG), WIPI2B(R108E), WIPI2B(S395A), and WIPI2B(S395E) were generated via quick change and subcloned into original plasmids. The SNAP backbone was originally obtained from New England Biolabs (NEB), and the Halo backbone was originally obtained from Promega.

Primary neuron culture {#s4-2}
----------------------

DRG neurons were isolated as previously described ([@bib62]) and cultured in F-12 Ham's media (Invitrogen) with 10% heat-inactivated fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin. For live-cell microscopy, DRGs were isolated from P21-28 (young), P90-120 (young adult), P480-540 (aged), or P730-760 (advanced aged) mice and plated on glass-bottomed dishes (MatTek Corporation) and maintained for 2 days at 37°C in a 5% CO~2~ incubator. Prior to plating, neurons were transfected with a maximum of 0.6 μg total plasmid DNA using a Nucleofector (Lonza) using the manufacturer's instructions. Relevant siRNA was co-transfected with plasmid DNA (25 pmol ON-TARGET plus SMARTpool Wipi2 siRNA, L-057690--01 from Dharmacon). For imaging experiments with siRNA, control neurons were transfected with 30 pmol Cy5-labeled non-targeting siRNA (Dharmacon) per dish and experimental neurons were co-transfected with 5 pmol Cy5-labeled non-targeting siRNA (Dharmacon) to identify which neurons received siRNA. For biochemistry siRNA experiments, control neurons were transfected with 25 pmol ON-TARGET plus non-targeting siRNA (D-001810--01 from Dharmacon). Microscopy was performed in low fluorescence nutrient media (Hibernate A, BrainBits) supplemented with 2% B27 and 2 mM GlutaMAX. For nucleofected constructs that yielded Halo- or SNAP-tagged proteins, DRG neurons were incubated with 100 nM of the appropriate Halo or SNAP ligand (SNAP-Cell 647-SiR, SNAP-Cell TMR-Star, or SNAP-Cell 430 from NEB; HaloTag TMR Ligand from Promega, silicon-rhodamine-Halo ligand from K. Johnsson, École Polytechnique Federale de Lausanne, Lausanne, Switzerland, or JF646-Halo ligand from Luke Levis, Janelia Farms, HHMI) for at least 30 min at 37°C in a 5% CO~2~ incubator. After incubation, DRGs were washed three times with complete equilibrated F-12 media, with the final wash remaining on the DRGs for at least 15 min at 37°C in a 5% CO~2~ incubator.

Mice of either sex within the indicated postnatal range (1 month, 3 months, 16--17 months or 24 months) were euthanized prior to dissection. All animal protocols were approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania.

Live-Cell imaging and image analysis {#s4-3}
------------------------------------

Microscopy was performed on a spinning-disk confocal (UltraVIEW VoX; PerkinElmer) microscope (Eclipse Ti; Nikon) with an Apochromat 100x, 1.49 NA oil immersion objective (Nikon) at 37°C in an environmental chamber. The Perfect Focus System was used to maintain Z position during time-lapse acquisition. Digital micrographs were acquired with an EM charge-coupled device camera (C9100; Hammamatsu Photonics) using Volocity software (PerkinElmer). Time-lapse videos were acquired for 10 min with a frame every 3 s to capture autophagosome biogenesis. Multiple channels were acquired consecutively, with the green (488 nm) channel captured first, followed by red (561 nm), far-red (640 nm), and blue (405 nm). DRGs were selected for imaging based on morphological criteria and low expression of transfected constructs. To minimize artifacts from overexpression, neurons within a narrow range of low fluorescence intensity were chosen for imaging, ensuring the analyzed neurons expressed low levels of the ectopic tagged proteins.

Time-lapse micrographs were analyzed with FIJI ([@bib74]). 'Stalled' biogenesis events were defined as mCherry-ATG13, mCherry-ATG5, or Halo-ATG5 puncta that remained visible for at least 5 min. 'Productive' biogenesis events were defined as mCherry-ATG13, mCherry-ATG5, or Halo-ATG5 puncta that persisted for less than 5 min and recruited GFP-LC3B.

Biochemistry {#s4-4}
------------

Brains or DRGs of non-transgenic mice were dissected and subsequently homogenized and lysed. Brains were homogenized individually in RIPA buffer \[50 mM NaPO4, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 1x complete protease inhibitor mixture (Roche), and 1x Halt protease and phosphatase inhibitor cocktail (Thermo)\]. DRGs were homogenized in RIPA buffer with a 1.5 mL pestle. Homogenized samples were lysed for 30 min on ice. For the siRNA and overexpression controls, isolated DRGs were plated at 120,000 neurons per 35 mm dish as described above for 2 DIV. For the Halo-WIPI2B overexpression controls, where indicated, neurons were treated with 100 nM BaflomycinA1 (BafA) for 4 hr prior to lysis. Neurons were washed with PBS (50 mM NaPO~4~, 150 mM NaCl, pH 7.4) and then lysed as above.

Samples were centrifuged at 17,000 x g at 4°C for 15 min. Total protein in each lysate was determined by BCA assay (ThermoFisher Scientific) so that equal amounts of protein were loaded into each lane. All supernatants were analyzed by SDS-PAGE, transferred onto FL PVDF membrane, and visualized with fluorescent secondary antibodies (Li-Cor) on an Odyssey CLx imaging system (Li-Cor). The specificity of relevant antibodies was confirmed by immunocytochemistry as described below or by immunoblot. See Table for antibodies used.

All western blots were analyzed with Image Studio (Li-Cor). Total protein was used as a loading control to control for differences in sample loading. The normalization factor is listed below each blot as a percent.

For brain lysate cytosolic and membrane fractions, brains were dissected from non-transgenic mice and subsequently homogenized and lysed. Brains were homogenized individually in Motility Assay Buffer (MAB) \[10 mM PIPES, 50 mM K-Acetate, 4 mM MgCl2, 1 mM EGTA, 2 mM PMSF, 210 μM leupeptin, 1.5 μM pepstatin-A, 52.8 μM N-p-Tosyl-L-arginine methyl ester, 20 mM DTT, and 1x Halt protease and phosphatase inhibitor cocktail (Thermo)\]. The homogenate was spun at 17,000 x g for 30 min at 4°C. The resultant supernatant was then spun 95,000 x g for 20 min at 4°C. The supernatant was the cytosolic fraction, and the pellet was resuspended in an equal volume of MAB.

Cell culture and immunoprecipitation {#s4-5}
------------------------------------

HeLa-M (A. Peden, Cambridge Institute for Medical Research) and HEK293 (ThermoFisher, R70507) cells were cultured in complete medium (DMEM supplemented with 10 fetal bovine serum and 2 mM GlutaMAX). Lipofectamine 2000 (Invitrogen) and FuGENE (Promega) were used to transiently transfect HEK293 and HeLa-M cells, respectively. Immunoprecipitation was performed 24 hr after transfection. Cells were permeabilized with TNTE buffer (20 mM Tris HCl, pH 7.5, 150 mM NaCl, 1% triton TX-100, 5 mM EDTA, and 1X Halt Phosphatase and Protease Inhibitor, ThermoFisher). The HeLa-M lysates were immunoprecipitated with 3 μg mouse monoclonal Anti-Halo (Promega, G9211) and Dynabeads Protein G (Invitrogen). The immunoprecipitated sample was cleaved from the Dynabeads by boiling in Orange Protein Loading Buffer (Li-Cor). GFP-labeled proteins ectopically expressed in HEK293 cells were immunoprecipitated with GFP-Trap beads. The HEK293 cells were routinely tested for mycoplasma and authenticated by STR (short tandem repeat) profiling by The Francis Crick Cell Services. HEK293 cells were used because they are of human origin, fast growing, easy to transfect, and express ectopic proteins without high toxicity. The HeLa cells were routinely tested for mycoplasma using the MycoAlert detection kit (Lonza, LT07) and authenticated by STR profiling using the GenePrint 10 system (Promega, B9510) at the University of Pennsylvania Perelman School of Medicine DNA Sequencing Facility.

Quantitative Real-Time PCR (qPCR) cDNA isolation from whole brain {#s4-6}
-----------------------------------------------------------------

Whole brains were collected from euthanized non-transgenic 3-month-old or 16--17 month-old mice and immediately frozen at −80°C. Brains were homogenized in 2 mL TRIzol reagent (ThermoFisher Scientific, 15596018). 2 mL TRIzol reagent and 800 μL chloroform were added after homogenization. Solution was vortexed for 15 s, incubated at room temperature for 5 min, and centrifuged at 12,000 x g for 15 min at 4°C. Clear aqueous phase was mixed with one volume of 200 proof ethanol. Mixture was transferred to Zymo Quick-RNA miniprep kit (Zymo Research, R1057). Total RNA was immediately transferred to Polytract mRNA Isolation System III (Promega, Z5310) to isolate mRNA. Isolated mRNA was immediately transformed into cDNA using M-MuLV Reverse Transcriptase (New England Biolabs (NEB), M0253L; other NEB reagents: S1330S, M0314S). Nucleic acid concentration and purity was monitored throughout isolation.

qPCR {#s4-7}
----

10 ng total cDNA was added to a 50 μL qPCR reaction with Luna Universal qPCR Master Mix (NEB, M3003G). Each biological sample was loaded in triplicate into qPCR plate. All biological samples for each gene tested were loaded into a single qPCR plate (Phenix Research Products, MPC-3425 and LMT-RT2), with a reference gene loaded into the same qPCR plate. All primers were initially identified through Primer Bank (<https://pga.mgh.harvard.edu/primerbank/index.html>) ([@bib81]; [@bib80]; [@bib94]; [@bib96]). Primers were optimized to have melting temperatures at 62°C and tested to ensure appropriate dynamic range. Final qPCR primers used were:

*Pgk1* Fwd (5'-ATGTCGCTTTCCAACAAGCTGACTTTGGAC),

*Pgk1* Rev (5'-GGACTTGGCTCCATTGTCCAAGCAGAATTTG),

*Rplp0* Fwd (5'-GGGCATCACCACGAAAATCTCCAGAGG),

*Rplp0* Rev (5'-CTGCCGTTGTCAAACACCTGCTGG),

*Ulk1* Fwd (5'-GCAAGTTCGAGTTCTCTCGCAAGGACC),

*Ulk1* Rev (5'-CCACGATGTTTTCGTGCTTTAGTTCCTTCAGG),

*Wipi1* Fwd (5'-GCTGCTTCTCTTTCAACCAAGACTGCACATC),

*Wipi1* Rev (5'-CACGTCAGGGATTTCATTGCTTCCATGGAC),

*Wipi2* Fwd (5'-CCAGGATAACACGTCCCTAGCTGTTGG),

*Wipi2* Rev (5'-CTCTCCACAATGCAGACATCTTCAGTGTCAG),

*Wdr45b* (*Wipi3*) Fwd (5'-CGGGTGTTTTGCATGTGGAATGGAAAATGG),

*Wdr45b* (*Wipi3*) Rev (5'-CAGATCATCACTTTGTTGGGAGGGTATTTCGG),

*Wdr45* (*Wipi4*) Fwd (5'-GCGCCATTCACTATCAATGCACATCAGAGTG),

*Wdr45* (*Wipi4*) Rev (5'-GGAGGAGTCGTGGCTGAAGTTAATGCAG),

*Map1lc3b* (*Lc3b*) Fwd (5'-CCCAGTGATTATAGAGCGATACAAGGGGGAG),

*Map1lc3b* (*Lc3b*) Rev (5'-CTGCAAGCGCCGTCTGATTATCTTGATGAG),

*Atg5* Fwd (5'-GGCACACCCCTGAAATGGCATTATCC),

*Atg5* Rev (5'-CCTCAACCGCATCCTTGGATGGAC),

*Atg2a* Fwd (5'-CTATCTGTTCCCAGGTGAACGGAGTGG), and

*Atg2a* Rev (5'-CTGGATGCAGCTGTGTCACGATGG).

qPCR was performed on a QuantStudio 3 Real-Time PCR System (ThermoFisher Scientific) controlled by QuantStudio Design and Analysis Software (ThermoFisher Scientific). Normalized target gene expression level is 2\^ΔΔCt for each gene relative to the indicated reference gene.

Immunofluorescence {#s4-8}
------------------

### Immunocytochemistry {#s4-8-1}

DRGs were isolated, plated, and cultured as described above. At 2 DIV, DRGs were fixed in pre-warmed 4% paraformaldehyde (Affymetrix) with 4% sucrose in PBS for 8 min at room temperature. Neurons were washed twice with 1X PBS, then incubated in ice-cold 100% methanol at −20°C for 8 min. Neurons were washed twice with 1X PBS, then incubated in detergent-free Cell Block (1X PBS with 1% BSA and 5% normal goat serum) for one hour at room temperature. DRGs were then incubated in Cell Block containing primary antibodies for one hour at room temperature. After three 5-min washes in 1X PBS, DRGs were incubated in Cell Block containing secondary antibodies for one hour at room temperature. For primary antibodies conjugated to fluorophores, DRGs were incubated in Cell Block containing conjugated primary antibodies overnight at 4°C. DRGs were washed three additional times in 1X PBS, then once with ddH~2~O. DRGs were then mounted in Prolong Gold, cured overnight in the dark at room temperature, and assessed by spinning disk confocal microscopy. See Table for antibodies used.

### Immunohistochemistry {#s4-8-2}

Extensor digitorum longus (EDL) muscles were dissected from 3-month-old or 16--17 month old non-transgenic mice. EDL muscles were subsequently immersion-fixed in 2% paraformaldehyde (Affymetrix) for 12 min at room temperature. After three washes in 1X PBS, EDL muscles were incubated in 10 μg/mL α-Bungarotoxin-tetramethylrhodamine (TMR-α-Btx, Sigma T0195) for 15 min at room temperature. After three 10-min washes in 1X PBS, EDL muscles were incubated in ice-cold 100% methanol for 5 min at −20°C. EDL muscles were rinsed in 1X PBS, followed by three 10-min washes in 1X PBS. EDL muscles were then incubated in detergent-free Block (1X PBS with 2% BSA) for 2 hours at room temperature. EDLs were then incubated in primary antibodies in detergent-free block overnight at room temperature. After three 10-min washes in detergent-free Block, EDLs were incubated in secondary antibodies in detergent-free Block for four hours at room temperature. EDLs were washed three times for 10 min per wash in 1X PBS. EDLs were mounted in VectaShield (Vector Labs) and assessed by spinning disk confocal microscopy. See Table for antibodies used.

Electron microscopy {#s4-9}
-------------------

DRGs from non-transgenic mice were isolated as above and plated as spot cultures on glass-bottomed dishes (MatTek Corporation) and maintained for 2 days at 37°C in a 5% CO~2~ incubator. DRGs were fixed with 2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1M sodium cacodylate buffer, pH 7.4, overnight at 4°C. For NMJs, non-transgenic mice were euthanized and subsequently perfused with 2.5% glutaraldehyde, 2.0% paraformaldehyde in 1X PBS. EDL muscles were dissected and post-fixed in 2.5% glutaraldehyde, 2.0% paraformaldehyde in 1X PBS overnight at 4°C. EDL muscles were further post-fixed in 2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1M sodium cacodylate buffer, pH 7.4. Fixed DRGs and NMJs were then transferred to the Electron Microscopy Resource Laboratory at the University of Pennsylvania, where all subsequent steps were performed. After subsequent buffer washes, the samples were post-fixed in 2.0% osmium tetroxide for 1 hr at room temperature and then washed again in buffer, followed by dH~2~O. After dehydration through a graded ethanol series, the tissue was infiltrated and embedded in EMbed-812 (Electron Microscopy Sciences, Fort Washington, PA). Thin sections were stained with lead citrate and examined with a JEOL 1010 electron microscope fitted with a Hamamatsu digital camera and AMT Advantage image capture software. Regions between DRG cell body densities with maximum neurite invasion were chosen for imaging.

Additional methods {#s4-10}
------------------

All image analysis was performed on raw data. Images were prepared in FIJI ([@bib74]); contrast and brightness were adjusted equally to all images within a series. Figures were assembled in Adobe Illustrator. Prism 6 (GraphPad) was used to plot graphs and perform statistical tests. Prism 8 (GraphPad) was used to plot graphs and perform statistical tests for [Figure 4G--I](#fig4){ref-type="fig"}. Statistical tests are indicated in the text and figure legends.

To quantify AV biogenesis, GFP-LC3B puncta were tracked manually using FIJI. An AV biogenesis event was defined as the de novo appearance of a GFP-LC3B punctum based on changes in fluorescence intensity over time. For GFP-LC3B puncta that were present at the start of the time-lapse series, only those puncta that increased in fluorescence intensity and/or area with time were counted as AV biogenesis events.
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\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Expression of WIPI2B counteracts age-related decline in autophagosome biogenesis in neurons\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

While the reviewers appreciate the potential new mechanism of a defect in autophagosome biogenesis in aged neurons, the data presented here are rather preliminary and some are confusing. The major comments that you will find below are all important to make this study more complete, but it would take more than the usual 2-month revision period that is allocated for submission of a revised manuscript.

Reviewer \#1:

Stavoe et al. report that autophagosome biogenesis is abrogated in neurons from aged mice when compared to young mice. In aged neurons, stalled Atg-13-positive but LC3B-negative structures accumulate. The amount of the WIPI2B protein is smaller in neurons of aged mice compared to young mice, and knockdown of WIPI2B or WIPI1A in young neurons sufficiently induces formation of stalled structures. Furthermore, overexpression of WIPI2B or WIPI1A in neurons from aged mice rescues the failure of autophagosome biogenesis. These results suggest that a decrease in WIPI2B is the cause of defects in autophagosome biogenesis in neurons in aged mice. Although these findings are timely and potentially important, it is unclear what the stalled structures in neurons of aged mice are and whether autophagy flux is indeed affected.

Major comments:

1\) The nature of stalled Atg-13-positive LC3B-negative autophagic structures is unclear. Are they autophagosome precursors, autophagosomes, or protein aggregates? In Figure 4, the authors show the presence of multilamellar bodies in neurons from aged mice, but whether these indeed represent stalled isolation membranes is not clear. It is essential to perform CLEM (or immuno-EM) to characterize the stalled structures. Are these undigested structures positive for multiple ATGs and LC3-family proteins except for LC3B as suggested in Figure5C-G?

2\) The in vivo data of stalled structures is also weak. CLEM or immune EM would be required for characterization of Atg9- and Atg13-positive structures in aged mice in Figure 3F. Antigen specificity of anti-Atg13 and anti-Atg9 antibodies used in immunohistochemistry of NMJs should also be checked.

3\) The authors do not investigate whether autophagy flux is indeed affected in neurons from aged mice. The authors should determine the protein and mRNA levels of p62, an autophagic substrate, in both brain and DRG lysates in Figure S6A and S6B, and also measure autophagic flux (e.g., lysosome-dependent LC3 degradation) in primary DRG neurons from young and aged mice.

4\) It was previously reported that WIPI2B interacts with ATG16L1 and recruit the ATG12-5-16L1 complex to autophagic membranes (Dooley et al., 2014). However, the present study shows that ATG5 and ATG16L1 can be recruited to autophagic membranes in WIPI2-depleted neurons. This apparent inconsistency needs to be clarified. Furthermore, the authors show that ATG16L1-binding activity of WIPI2B is required for autophagy restoration in aged neurons (Figure 7C), whereas ectopically expression of WIPI1A, which cannot bind to ATG16L1 (Dooley et al., 2014), could restore autophagy (Figure 7F). This discrepancy should also be explained.

5\) Why does only LC3B among the LC3/GABARAP family proteins fail to localize to autophagic structures in aged neurons (Figure 5)? It is expected that, if the ATG5-12-16L1 complex is recruited, this complex can recruit LC3B (Fujita et al., 2008a).

6\) The authors claim that the WIPI2 protein level is decreased in neurons in aged mice, but the data are rather weak. In Figure 6A, the amount of WIPI2 seems not much different between young and aged DRG. Data from more than three mice should be shown and quantified. Also in Figure S6A, the amount of ATG proteins should be quantified and statistically analyzed. Inclusion of other key ATGs is required to show that WIPI2B is specifically depleted neurons from aged mice.

7\) The role of WIPI1 has been controversial (Polson et al., 2010, Behrends et al., 2010, DeJesus et al., PMID:27351204). To convince that WIPI1A is important in neurons in Figure 6E, rescue experiments using siRNA-resistant WT-WIPI1A, WIPI1A (FTTG) and WT-WIPI2B should be performed. Is the phenotype of WIPI1A-knockdown cells similar to that of WIPI2B-knockdown cells? Do stalled structures appear in WIPI2B- as well as WIPI1A-knockdown cells from young mice?

8\) In Figure 7, protein levels of overexpressed WIPI2B and WIPI1A should be shown. Are they similar to those in neurons from young mice? Is autophagy flux improved upon WIPI2B or WIPI1A overexpression?

Reviewer \#2:

Stavoe and Holzbaur ask if autophagsome biogenesis is altered during aging or the development neurodegenerative disease. Using a model system of in vitro cultures of primary DRG neurons from young or aged mice they show initial biogenesis events proceed normally but that in aged neurons autophagosomes do not acquire LC3B. In addition they appear to retain ATG13, and 14, and also are positive for the ATG12-5-16L1 complex. They furthermore show differences in Atg9 dissociation from the forming autophagosomes, leading to their hypothesis that in aged neurons autophagosome formation stalls at the stage of acquiring LC3B. Surprisingly they show that LC3A and the GABARAP familes when overexpressed can associate with the stalled autophagosomes but does not rescue. To understand the cause of the stalling ask if the ATG proteins have different mRNA or protein and discover WIPI2 levels decrease but not WIPI1. They show that both WIPI1 and WIPI2 can rescue of LC3B recruitment. Finding a decrease in WIPI2 in aged neurons they show WIPI2B can rescue LC3 recruitment in aged neurons dependent upon the lipid binding motif in WIPI2B, but not with a mutant unable to bind ATG16L1. Interestingly, WIPI1 can also rescue aged neurons.

The manuscript is well written but the data is at times confusing and is largely correlative. The hypotheses are based on pre-existing knowledge and is lacking any new mechanistic insight in particular regarding the WIPI proteins despite some obvious questions coming from their data.

Major points:

1\) The definition of a stalled autophagosome gets confusing. The definition seems to be lack of accumulation of LC3B but given the data on LC3A, and the GABARAPs this should be revisited. Do the autophagosome in the old mice is there endogenous GARARAP on the LC3B negative autophagosomes? How do the authors explain the differences between the LC3B and LC3A, and the GABARAPs regarding their association with the stalled autophagosomes?

2\) What is the correlation between the decrease in WIPI2 levels and the lack of recruitment of LC3B. If ATG12-5-16L1 are present LC3B should be recruited. Furthermore, the ATG16L1 binding mutant of WIPI2b cannot rescue aged neurons suggesting that the defect is the recruitment of the Atg12-5-16L1 complex but the authors show the ATG12-5-16L1 is present.

3\) What is the molecular basis for the requirement for both WIPI1 and WIPI2? In particular as the WIPI1 levels do not change over age? In this regard the experiment test the effect of \"restore WIPI1 levels\" in Figure 7F is confusing.

4\) The knockdown experiments are not conclusive for WIPI1 as the authors themselves point out only 37% (WIPI1) knockdown is achieved. How do they know the cells they study are depleted of WIPI1?

Reviewer \#3:

This manuscript by Stavoe et al. demonstrated that aging influenced the biogenesis of constitutive autophagosomes at the elongation/closure stage, but not at nucleation/ initiation stage. In aged neurons, the aberrant autophagic structures (stalled AVs) were shown to be ATG13-positive, but could not form LC3-positive autophagosomes. The defect was suggested due to reduced levels of WIPI2 in aged neurons and overexpression of WIPI2 in these neurons restored autophagosome biogenesis. This is an interesting topic and could be potentially beneficial for therapeutic purpose. However, the quality of the data, especially fluorescent images, is not satisfied and the evidences presented fail to fully support the main conclusion of the work.

Major concerns:

1\) The authors showed that the stalled AVs maintained stably levels of mCherry-ATG13/ATG5, without recruitment of LC3B, indicating that early autophagic structures accumulate in aged neurons. However, whether these puncta are autophagic structures is still a question. mCherry is easy to form protein aggregates, especially when expressed at high levels. The formation of mCherry tagged ATG13/ATG5 puncta may be due to decreased degradation capability of proteasome and/or lysosome function in aged neurons. According to Figures 2B, 3A, S1B and S2B, the authors only showed the already exist mCherry-ATG13/ATG5 puncta. Will these puncta eventually disappear? How about newly formed puncta? Can they all become LC3 positive or not? The authors also should perform endogenous antibody staining to comfirm these data.

2\) Quantification data should be provided for images in Figures 3E, 3F and S3A-D. Are there more ATG13 puncta accumulated in aged NMJs, compared to young NMJs?

3\) The EM results in Figure 4 are not convincing. The multilamellar structures have been demonstrated to belong to lysosomal compartments by multiple literatures. Immuno-EM should be provided to support that these are ATG13 and/or ATG5 positive structures. Quantification data are also needed.

4\) Compared to DRG lysates of 3 mo, the decrease of WIPI2 levels in lysates of 16-17 mo is too subtle. Although the difference from brain lysate is obvious, brain lysates are always contaminated with many other types of neural and non-neural cells. If the recruitment of LC3 and autophagosome formation are defective in aged mice, why the LC3-I and II levels are not changed? How about the levels of autophagic substrate p62?

5\) Previous study by Dooley et al. showed that WIPI2 links LC3 conjugation to PI3P by recruiting ATG12-5-16L1 complex. The authors suggested that the reduced WIPI2 levels was the reason for impaired LC3 puncta formation. But this could not explain why stalled AVs are all positive for ATG16L1 and ATG5.

6\) Is there any functional defect caused by impaired autophagy in aged neurons, eg. defective axonal growth? Can these defects be rescued by overexpression of WIPI2?

\[Editors' note: what now follows is the decision letter after the authors submitted a new version of their paper for consideration.\]

Thank you for submitting your article \"Expression of WIPI2B counteracts age-related decline in autophagosome biogenesis in neurons\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Ivan Dikic as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: James H Hurley (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The authors start with the observation that the rate of autophagosome biogenesis is significantly decreased in neurons from aged mice. Then they show that when autophagosme biogenesis stalls in aged mice neurons, the stalled autophagosomes fail to recruit LC3B, while recruitment of Atg13, DFCP1, and Atg5/Atg12/Atg16 is not affected. Atg9 is retained in the stalled autophagosomes. Inspired by these data, the authors find that overexpression of WIPI2B restores the rate of autophagosome biogenesis in aged mice, and that rescue requires both PI3P-binding and Atg16-binding functions of WIPI2B. Oddly, WIPI2B expression is unaffected. The authors do find, however, that dephosphorylated WIPI2B is required for productive autophagosome biogenesis, and that WIPI2B is dynamically rephosphorylated at the autophagosome to enable the autophagosome to grow.

The last part of the study, concerning the aspect of WIPI2B responsible for the deficit in aging and therefore the mechanism of rescue, is the only part that it is not fully convincing. The question as to the identity of the putative phosphatase is left open. This work advances the field and suggests an interesting avenue for anti-aging interventions. The somewhat less convincing part of the story concerns WIPI2B phosphoregulation.

Essential revisions:

The major concern of all reviewers was the last part of the manuscript and it was generally accepted that WIPI2 phosphorylation section needs extra experimental support. The authors should perform some additional experiments to validate their conclusion that dysfunctional regulation of WIPI2B phosphorylation underlies the failure of autophagosome maturation in aging neurons. They do not need to identify the kinase/phosphatase involved in this regulation, but should strengthen their data as suggested by reviewer 1 (comment 6), reviewer 2 (comments 6-10) and reviewer 3. They should also provide some quantification of the EM data in Figure 1 to support their claims (reviewer 1 comment 1 and reviewer 2 comment 1) and measure autophagic flux upon WIPI2B overexpression. The authors should be able to address these points, as well as the minor comments raised by the three reviewers within two months.

Reviewer \#1:

The specific requirement of LC3B recruitment over other ATG8s for autophagosome progression, the presence of ATG9 in stalled autophagosomes, and the nature of the multi-lamellar aberrant vesicles accumulated with age, should at least be further discussed.

1\) Figure 1 -- rate of AV biogenesis (as measured by LC3B-positive punctae) is decreasing with age, but how does this relate to overall numbers of AVs in DGNs? Multiple studies have suggested increases in Atg8-positive punctae over time (Hansen et al., 2018). It will be important to discuss similarities and differences to published data.

Regarding EM data, the size and frequency of the multilamellar structures in young vs old neurons must be provided to quantitatively support claims.

2\) Figure 2 -- the conclusion from Figure 2 that there are no changes in elongation of AVs, is not fully supported by the data in Figure 2E (which is out of order, following the role in the biogenesis process). Moreover, Figure 2H is missing time points analyzed for initiation and elongation, and should be added for consistency.

3\) Figure 4 -- Authors report ATG9 remains in stalled autophagosomes. As WIPI4 is required for ATG9 retrieval, the authors should consider analyzing levels of WIPI4 with age. Moreover, Figure 4B is missing young data (subsection "Stalled AVs recruit autophagosome biogenesis components").

4\) Figure 5 -- The authors need to quantify and present statistics for the fraction of stalled events that could recruit ATG12, ATG7, ATG16L1, and ATG3.

Furthermore, the authors interestingly find that all ATG8 members except LC3B are recruited to autophagosomes in old neurons. However, no data are shown towards the experiments by which overexpression of these family members have been tested (subsection "Stalled AVs recruit autophagosome biogenesis components"); this is key to add, including controls to assess levels of overexpression. How do the overall number of other ATG8 proteins change over time? Moreover, knowing that the machinery required for ATG8 recruitment (including WIPI2 and ATG16L1) is the same for all ATG8 proteins, the authors should at the very least discuss or speculate what is special for LC3B among other homologs.

5\) Figure 6 -- WIPI2B overexpression in old neurons restored autophagosome biogenesis. However, it is not clear whether these autophagosomes are bona fide autophagosomes. The authors should use a lipidation mutant form of LC3B to test the identity of the observed structures, i.e., to assess if they are likely to be autophagosomes versus random aggregates. Flux assay should also be performed to assess whether autophagy is induced.

EM micrographs show accumulation of multilamellar structures in neurons with age, that the authors claim are of autophagic origin. While the reviewer understands that labeling these structures with autophagy markers may be technically challenging, the authors should at least consider analyzing how WIPI2 levels affect their numbers (ideally decreasing them).

6\) Figure 7 -- The authors hypothesized that the dynamic phosphorylation of WIPI2B is key for the recruitment of LC3B and autophagosome formation. However, evidence to support this is not solid (e.g., evaluation of cells overexpressing the phospho-mimetic mutant, including expression levels, localization etc are missing, and Figure 8A is especially open-ended). One possible experiment the authors could do is to express WIPI2B (S395A) and WIPI2B (S395E) in the presence of siRNA for endogenous WIPI2 to test if these two forms of WIPI2B are recruited to the forming autophagosome in a sequential manner. Importantly, the authors must test their pWIPI2 antibodies specificity using a negative control, e.g., immunoprecipitated WIPI2 phospho-null mutant.

The authors describe that age-dependent defects on autophagosome biogenesis are likely due to aberrant post-translational modification of WIPI2 rather than WIPI2 levels. How can they explain that WIPI2 overexpression then rescues age-dependent defects? This point must be discussed in detail.

Reviewer \#2:

1\) Although not absolutely required, it would be nice to get some numbers to support the conclusions drawn based on Figure 1 C-J that aged neurons show more aberrant autophagic vesicles.

2\) Both the text and the figure legends of several figures (e.g. Figure 2 and 3) fail to mention that quantification of puncta formed is based on live-cell imaging of neurons transfected with fluorescent constructs. The figures should also be clearly labeled with the protein analyzed (e.g. Figure 2B-D should be labeled mCherry-ATG13 instead of ATG13) for the reader to know if one is looking av transfected or endogenous protein. They should also explain (at least in the Materials and methods) how the quantifications (rate of formation) were done.

3\) To confirm that the reduced level of autophagosome formation seen with age is real, and not due to reduced level of transfection in aged neurons, the authors should show by western blot that the level of transfection is equal for young and old neurons. Moreover, they should confirm their data using staining for endogenous proteins (LC3).

4\) In Figure 4E-F, the authors nicely show the presence of stalled AVs in vivo in old mice, as detected by colocalization of ATG9 and ATG13. They should also show that these structures lack LC3B to confirm their in vitro data.

5\) In Figure 6 the authors ask if WIPI2 could be involved in the stalling phenotype of AVs seen in neurons from aged mice. They should first show if WIPI2 is recruited or not to stalled AVs, as they have done for all other autophagy markers. Now, they directly shown the importance of WIPI2 and its binding to PI3P and ATG16L1 in autophagosome biogenesis in primary neurons, which is nice and expected, but the transition would have been better if they could show 6E-H before A-D (at least for WT WIPI2).

6\) In Figure 7 they show nicely that de-phosphorylation of WIPI2B at forming AVs seems to be required for recruitment of LC3B and AV biogenesis. However, they do not detect a difference in protein levels of total or phosphorylated WIPI2B with age and therefore propose that changes in cytosol/membrane levels of phosphorylated WIPI2B could change with age. This can be easily tested (and should be done) by a crude cytosol/membrane fractionation of their cell lysates or alternatively by gradient fractionation to see if the l specificity of membrane binding of P-WIPI2B is changed. From the blots in Figure S4 and S5 it seems like the majority of WIPI2B is phosphorylated and that the upper band of the WIPI2 blot correspond to the P-WIPI2 band. Is this correct?

7\) Figure 7H; this figure is confusing. The authors claim that it shows a stalled AV where WIPI2B S395E is not recruited, but how do we know ATG5 and WIPI2B S395E are expressed?

8\) Figure 8B: the figure suggests a model where WIPI2B de-phosphorylation regulates its membrane recruitment and binding PI3P. To be able to conclude about this, they should do the membrane fractionation experiments suggested above and/or colocalization with PI3P.

9\) Furthermore, the model indicates that WIPI2B de-phosphorylation is important for the initial membrane recruitment of LC3B (and AV biogenesis), while WIPI2B re-phosphorylation is required for growth of LC3B positive structures. Their data are however not of sufficient strength to conclude about this and they should consider to modify the model as well as the sentence stating: \" Further, we find that the dynamic regulation of WIPI2B phosphorylation at the isolation membrane is integral to autophagosome biogenesis, as our results suggest that dephosphorylated WIPI2B is required for recruitment of LC3B to the isolation membrane, while phosphorylated WIPI2B promotes expansion of the autophagosome\".

10\) It is puzzling that the WIPI2B S395E mutant is not recruited to the early structures, as there is no difference in recruitment of DFCP1 (showing the presence of PI3P) and ATG5-12-16L1. Is the WIPI2B S395E mutant able to interact with PI3P and ATG16L1?

Reviewer \#3:

The data are generally quantified and statistics included (with description of which test used in the figure legends), but the authors should include more information about the software used for quantification of rate of AV formation.

This conclusion that autophagosome formation slows in aged mouse neurons is mainly supported by Figure 1 and Figure S1, which are quite convincing. Could the authors give more details about the definition of the rate of autophagosome biogenesis, i.e. LC3B puncta formation per min or mature autophagosome formation per min?

Figure 2, Figure 3, and part of Figure 5 support the conclusions about the step at which the defect occurs. Figure 4 and 5 show that Atg9 is retained in the stalled autophagosomes, convincingly. These findings are also quite clear. I am curious about the destiny of the stalled autophagosomes. Are they eventually degraded by lysosomes? This should be discussed.

Figure 6 contains the key rescue data. It is interesting that WIPI2B function depends on Atg16-binding, but the Atg16 recruitment is not affected in aged mouse neuron. Please discuss this.

\[Editors' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"Expression of WIPI2B counteracts age-related decline in autophagosome biogenesis in neurons\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Eve Marder as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Anne Simonsen (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The authors show that the rate of autophagosome biogenesis is significantly decreased in neurons from aged mice. The authors find that overexpression of WIPI2B restores the rate of autophagosome biogenesis in aged mice, and that rescue requires both PI3P-binding and Atg16-binding functions of WIPI2B. The authors propose that dephosphorylated WIPI2B is required for productive autophagosome biogenesis, and that WIPI2B is dynamically rephosphorylated at the autophagosome to enable the autophagosome to grow. The last part of the study, concerning the aspect of WIPI2B responsible for the deficit in aging and therefore the mechanism of rescue, has been addressed in the revised version. The authors have made significant effort to address the reviewer\'s comments, including further proving the relevance of WIPI2B phosphorylation in autophagosome biogenesis. Specifically, the authors added an experiment to quantify the membrane/cytosolic ratio of phospho-WIPI2B and found that phospho-WIPI2B is less likely to be associated with the membrane. Overall, the work has been improved based on the initial review. This work advances the field and suggests an interesting avenue for anti-aging interventions and all reviewers were positive about the overall message of the manuscript.

Essential revisions:

Although the authors have convincingly shown that overexpression of WIPI2B or a phospho-null version of this protein in aged neurons restores autophagosome biogenesis, the sequential phosphorylation model of WIPI2B to control autophagosome biogenesis should be more carefully discussed and main messages on dynamics toned down.

1\) Overexpression of both wild type or phospho-dead WIPI2(S395A) can rescue autophagosome biogenesis. How do the authors explain that a transition between dephosphorylation and phosphorylation is required for autophagosome biogenesis? The authors found that WIPI2 proteins levels increased with age in DRG neurons (Figure 6---figure supplement 1), but this result is discussed as if there is no change of WIPI2 levels with age. Combined with the observation that phosphorylation of WIPI2 is unchanged over time, this raises the possibility that overexpression of WIPI2 might not automatically lead to increases in phosphorylation (as argued by the authors in a rebuttal response). This brings about new questions, like how much (ie how many fold) is WIPI2 actually overexpressed in neurons compared to the age-associated increase observed, and has increases in WIPI2 phosphorylation (including over time) indeed been verified in this setting?

2\) In Figure 5 A-E, the authors used co-localization of ATG9 with ATG5 to identify stalled AV. However, while the authors showed representative pictures in Figure 5---figure supplement 1 that some LC3B homologs co-localize with both ATG9 and ATG5, the authors used ATG5 alone to identify stalled AV in Figure 5 F-J. It is possible that these vesicles may be functional autophagic vesicles with other LC3 homologs instead of LC3B. The authors may consider these as stalled AV as ATG5 stay long on the vesicle, but an alternative explanation may be that autophagic vesicles with other LC3 homologs have a different dynamics compared to that of LC3B.

Figure 2L -- The number of ATG5-positive punctae were found to decrease over time, as now directly stated in the paper, but the significance of this result is not discussed at all.

3\) Although the authors do not wish to make conclusions about their newly conducted flux assays, the provided diagram (which unfortunately is not accompanied with a figure legend, making it impossible to fully evaluate) may indicate that autophagy is still active in aged DRG neurons. If so, how would the authors explain the remaining autophagy activity with a decreased biogenesis of autophagosome vesicles in aged neurons?

4\) Missing data: Data showing ectopic overexpression of different mAtg8s to test LC3B recruitment to stalled AVs were not included, as requested by this reviewer -- this makes it impossible to evaluate the full experiment, including the negative data.

Quantification data is missing in Figure 4E-F. Authors should provide how many events they have observed in young and old NMJs.

5\) The authors\' argument not to cite Berjarano et al., 2018 because the study is not conducted in neurons is not valid. This study directly tested and showed, for the first time, an age-related decline in transport of autophagosomes, a conceptual advance that it relevant to this paper\'s findings, irrespective of cell type.

10.7554/eLife.44219.031

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> Thank you for submitting your work entitled \"Expression of WIPI2B counteracts age-related decline in autophagosome biogenesis in neurons\" for consideration by eLife. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The reviewers have opted to remain anonymous.
>
> Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in eLife.
>
> While the reviewers appreciate the potential new mechanism of a defect in autophagosome biogenesis in aged neurons, the data presented here are rather preliminary and some are confusing. The major comments that you will find below are all important to make this study more complete, but it would take more than the usual 2-month revision period that is allocated for submission of a revised manuscript.

The three referees who reviewed our initial submission at eLife concluded that the manuscript was timely and potentially important, but significantly more work was required to fully develop the story. We agree, and have spent the last 10 months refining our study, focusing on the new and important biological insights we have gleaned. Therefore, we are happy to once again submit this work to *eLife* for consideration for publication.

However, we are requesting that it be considered as a new submission because the direction that the work took was not always the same as that suggested by the initial reviewers. Many of their suggestions were helpful, but we also profited from in-depth discussions with other scientists in the field. In fact, these discussions led to a very exciting new collaboration with Dr. Sharon Tooze, an autophagy expert who is now a co-author of the study.

Importantly, our understanding of the underlying mechanisms has evolved significantly. While initially we thought the deficit might be due to declining levels of WIPI2, based on reviewer feedback we pursued this question in more detail. Extensive quantitative analysis of RNA and protein levels indicate that aging does not significantly lower levels of WIPI2. Instead, aging causes a local mis-regulation of WIPI2 phosphorylation. These studies in turn have provided new and very timely insights into the role of WIPI2B as a master regulator of autophagosome

formation and growth in neurons, through a targeted phosphorylation that is locally regulated within the axon tip. This direction provided a clearer molecular explanation of the aging-dependent decline in autophagosome formation.

In summary, while the points raised by the review of our initially submitted manuscript were helpful in further developing this work, our additional experimental observations have led to a significantly different submission. We feel that this work is best viewed on its own merits. Thus, we request that this current submission be handled as a new, rather than revised, manuscript.

We also agreed with the reviewers that the specific role of WIPI1 in autophagosome biogenesis is not yet clear so our initial observations on WIPI1 are not included in this new, more focused manuscript. While our unpublished data indicate that WIPI1 is required for autophagosome formation, the underlying mechanisms remain to be fully determined.

While we valued the suggestions to further develop the EM approaches, potentially through immuno-EM or CLEM, we focused instead on a more molecular analysis of autophagosome biogenesis. EM is a valuable but qualitative approach; instead we focused on more quantitative measures of the aging deficit we are reporting.

The reviewers did bring up an interesting question, that while Atg16L1 is recruited successfully to stalled autophagosomes, lipidated LC3B is not incorporated into the stalled structures seen in neurons from aged mice. This observation points out the current limitations in our overall understanding of the autophagosome biogenesis pathway. These results, in conjunction with other recent observations, suggest that LC3B recruitment is not sufficient for AV generation and elongation. In contrast, our new data indicate that dynamic WIPI2B phosphorylation is required, and this is what we have focused on during our revisions.

Finally, we did look in detail to see if flux was altered or autophagosome substrates such as p62 accumulated in neurons from aged mice. We saw no change in the overall LC3I/II ratio in either aged neurons or aged brain, and did not note any changes in p62 with age. However, these are insensitive measures of axonal autophagy, which is compartmentalized in neurons and does not require receptors involved in selective autophagy such as p62. Importantly, we are not studying

a genetic knockout, we are examining the effects of the normal aging process on axonal autophagy. Thus, the downstream effects of aging-related deficits in autophagosome formation are likely to be less marked, and may require specific challenges to the system such as induction of proteotoxic stress, which we hope to test in future studies.

\[Editors' note: the author responses to the review of the new version of their paper follow.\]

> Essential revisions:
>
> The major concern of all reviewers was the last part of the manuscript and it was generally accepted that WIPI2 phosphorylation section needs extra experimental support. The authors should perform some additional experiments to validate their conclusion that dysfunctional regulation of WIPI2B phosphorylation underlies the failure of autophagosome maturation in aging neurons. They do not need to identify the kinase/phosphatase involved in this regulation, but should strengthen their data as suggested by reviewer 1 (comment 6), reviewer 2 (comments 6-10) and reviewer 3. They should also provide some quantification of the EM data in Figure 1 to support their claims (reviewer 1 comment 1 and reviewer 2 comment 1) and measure autophagic flux upon WIPI2B overexpression. The authors should be able to address these points, as well as the minor comments raised by the three reviewers within two months.

We thank the reviewers for their thoughtful discussion of our work. We agree with the overall conclusions -- our work describes a novel and potentially important age-dependent deficit in autophagosome formation in primary neurons from aging rodents. Rescue experiments provide strong support for the mechanistic interpretation that there is an age-dependent dysfunction in WIPI2B phosphorylation, but further experiments addressing the role of WIPI2 phosphorylation would strengthen this point. We have followed the specific suggestions provided, and now include data that more firmly establish this point, including the requested information on the specificity of the phospho-specific WIPI2 antibody.

Importantly, we found the insights of Reviewer 2 to be correct: fractionation experiments demonstrate that phosphorylated WIPI2 is significantly less likely to be associated with the membrane fraction than is the total pool of endogenous WIPI2 when examining brain lysates from either young or aging mice. We measured a membrane/cytosolic ratio of 5.8% for P-WIPI2 vs. 12.6% for total WIPI2 for 3-month mice (p=0.0001 by one-way ANOVA) and a membrane/cytosolic ratio of 5.0% for P-WIPI2 vs. 9.7% for total WIPI2 for 16-month mice (p\<0.003 by one-way ANOVA). These data are now included in the revised Figure 8B.

To address the other key points, we now provide a quantitative analysis of our EM data. By EM analysis, we find that 80.4% of autophagosomes in the distal tips of primary DRG neurons are morphologically normal, significantly different from the 34.0% that are morphologically normal in neurons from aged mice (n=56 from young neurons, n=153 from aged neurons; p\<0.0001). We have added this quantification to the text of the revised manuscript, and also include the relevant graph in [Author response image 1](#respfig1){ref-type="fig"}. We found no significant difference in AV size by age or AV type (normal vs. multilamellar).

![](elife-44219-resp-fig1){#respfig1}

Further, we examined autophagic flux upon WIPI2B overexpression. Using the western blot assay with BaflomycinA, we did not detect a change in autophagic flux with overexpression of wild type WIPI2B. However, since transfection efficiencies are very low for primary neurons, it is not surprising that we could not detect a change in autophagic flux from cultured DRG neurons. See [Author response image 2](#respfig2){ref-type="fig"}.

![DRG neurons were harvested from 3-mo- or 16-17-mo-old mice and co-transfected with mCh-ATG5 and the indicated Halo-tagged construct.\
Neurons from 2 mice were pooled during isolation and then split into two samples and nucleofected and plated separately. After 2 DIV, neurons were treated with 2 uL DMSO or 2 uL Bafilomycin A1 (100 nM final concentration) for 4 hours. Neurons were then lysed and harvested. Equal amounts of total protein were loaded onto a SDS-PAGE gel and assessed by immunoblot. LC3 levels were first normalized to total protein, then the LC3-II/LC3-I ratio was calculated and plotted.\</](elife-44219-resp-fig2){#respfig2}

> Reviewer \#1:
>
> The specific requirement of LC3B recruitment over other ATG8s for autophagosome progression, the presence of ATG9 in stalled autophagosomes, and the nature of the multi-lamellar aberrant vesicles accumulated with age, should at least be further discussed.

We now extend our discussion to note the growing literature indicating that the LC3/GABARAP proteins are not functionally redundant. We also discuss the potential significance of the continued association of ATG9 with stalled autophagosomes and how this may explain the age-dependent accumulation of multi-lamellar vesicles. However, in the absence of further mechanistic insights, we would prefer to keep this speculation brief. The relevant sentences are highlighted in the revised manuscript.

> 1\) Figure 1 -- rate of AV biogenesis (as measured by LC3B-positive punctae) is decreasing with age, but how does this relate to overall numbers of AVs in DGNs? Multiple studies have suggested increases in Atg8-positive punctae over time (Hansen et al., 2018). It will be important to discuss similarities and differences to published data.

Our study is the first that we are aware of to directly investigate the effects of aging on autophagosome biogenesis in neurons. Other studies have focused on steady state measures of AV content as a function of aging. It is highly likely that other steps in the autophagy pathway, such as fusion, maturation, and clearance, are also affected by aging, leading to the observed increases in Atg8-positive puncta seen in other model systems. We clarify this point in the revised manuscript.

> Regarding EM data, the size and frequency of the multilamellar structures in young vs old neurons must be provided to quantitatively support claims.

As requested, we now provide a quantitative analysis of our EM data. By EM analysis, we find that 80.4% of autophagosomes in the distal tips of primary DRG neurons are morphologically normal, significantly different from the 34.0% that are morphologically normal in neurons from aged mice (n=56 from young neurons, n=153 from aged neurons; p\<0.0001). As requested, we also quantified the size of the autophagic vesicles and multilamellar structures and found no change with age or type of structure. See [Author response image 3](#respfig3){ref-type="fig"}.

![](elife-44219-resp-fig3){#respfig3}

> 2\) Figure 2 -- the conclusion from Figure 2 that there are no changes in elongation of AVs, is not fully supported by the data in Figure 2E (which is out of order, following the role in the biogenesis process). Moreover, Figure 2H is missing time points analyzed for initiation and elongation, and should be added for consistency.

The rate of formation of ATG5 puncta per min is modestly decreased in DRG neurons from 24-month old mice as compared to 3-month old mice, but not to 1-month or 16-17-month-old mice, as noted in the figure. We now point this out within the text of the revised manuscript. We have also switched the order of the panels, as requested. Finally, we measured the rates of DFCP1 puncta formation at both the 1-month and 24-month time points, as requested, and found that these rates were not significantly different than the previously measured rates for neurons from mice that were 3- or 16-17-months old. These additional data have been added to the revised Figure 2.

> 3\) Figure 4 -- Authors report ATG9 remains in stalled autophagosomes. As WIPI4 is required for ATG9 retrieval, the authors should consider analyzing levels of WIPI4 with age. Moreover, Figure 4B is missing young data (subsection "Stalled AVs recruit autophagosome biogenesis components").

We were able to find antibodies to WIPI3 and WIPI4 and now include those blots and analysis of all WIPI levels with age in Figure 6---figure supplement 1. We also assessed the mRNA levels of WIPI3 and WIPI4 and include that data in Figure 6---figure supplement 1. A reference to Figure 4D was added for the young ATG9 data.

> 4\) Figure 5 -- The authors need to quantify and present statistics for the fraction of stalled events that could recruit ATG12, ATG7, ATG16L1, and ATG3.

We did not observe deficits in the recruitment of any of these factors to either productive or stalled events in neurons from aged mice. We quantified the colocalization of endogenous ATG16L1, ATG5, and ATG9 in fixed neurons from aged mice. Of the puncta that were both ATG5- and ATG9-positive, 100% were also ATG16L1-positive (37 puncta from 35 neurons). There were 30 additional puncta that were ATG5- and ATG16L1-positive puncta that were ATG9-negative.

> Furthermore, the authors interestingly find that all ATG8 members except LC3B are recruited to autophagosomes in old neurons. However, no data are shown towards the experiments by which overexpression of these family members have been tested (subsection "Stalled AVs recruit autophagosome biogenesis components"); this is key to add, including controls to assess levels of overexpression. How do the overall number of other ATG8 proteins change over time? Moreover, knowing that the machinery required for ATG8 recruitment (including WIPI2 and ATG16L1) is the same for all ATG8 proteins, the authors should at the very least discuss or speculate what is special for LC3B among other homologs.

We did not observe clear differences in expression levels among the members of the LC3/GABARAP family over time (Figure 6---figure supplement 1). While we appreciate the reviewer's curiosity, we are very hesitant to speculate about the functional differences among these proteins in the absence of more specific data, although as noted above, we now include a brief discussion of the growing body of literature indicating functional differences among these proteins. However, it is interesting to note that the induced recruitment of LC3B to the nascent autophagosome caused by LC3A overexpression was not sufficient to resolve the stalled event, suggesting that it is not the recruitment or lipidation of LC3B that is the issue, but instead this is a marker for an upstream problem, likely related to the sustained presence of ATG9. We did attempt to address this point by overexpressing each of the constructs in DRGs and assessed the levels by western blot. However, due to technical limitations, the antibodies specific to each mAtg8 were not able to detect either endogenous or overexpressed levels in cultured DRGs. In addition, we select neurons to image within a narrow fluorescence intensity range. As fluorescence intensity is directly correlated to total construct expression, we can be certain that we are imaging and analyzing neurons expressing roughly similar levels of each of the mAtg8s. We have modified the Materials and methods to clarify this.

> 5\) Figure 6 -- WIPI2B overexpression in old neurons restored autophagosome biogenesis. However, it is not clear whether these autophagosomes are bona fide autophagosomes. The authors should use a lipidation mutant form of LC3B to test the identity of the observed structures, i.e., to assess if they are likely to be autophagosomes versus random aggregates. Flux assay should also be performed to assess whether autophagy is induced.

![](elife-44219-resp-fig4){#respfig4}

The morphology, rate of formation, and dynamics of GFP-LC3B-positive structures induced in aged neurons by over-expression of WIPI2B are consistent with the conclusion that they are bone fide autophagosomes. At the low levels of GFP-LC3B expression observed in the transgenic mouse (Mizushima, 2004), we do not see random aggregate formation, a likely artifact of high expression levels. As requested, we used a lipidation mutant to confirm that GFP-LC3B-positive structures are not random aggregates.

As requested, flux assays were performed, but this is a less sensitive assay that is insufficient to detect changes at the intracellular level. The flux assays are performed on an entire plate of cultured neurons. Since the transfection rate of neurons is very low, it is not surprising that we did not detect any changes in autophagic flux. See [Author response image 2](#respfig2){ref-type="fig"}.

> EM micrographs show accumulation of multilamellar structures in neurons with age, that the authors claim are of autophagic origin. While the reviewer understands that labeling these structures with autophagy markers may be technically challenging, the authors should at least consider analyzing how WIPI2 levels affect their numbers (ideally decreasing them).

The reviewer is correct, this experiment is too technically challenging to provide quantitative insights given the low transfection efficiencies observed for primary neurons.

> 6\) Figure 7 -- The authors hypothesized that the dynamic phosphorylation of WIPI2B is key for the recruitment of LC3B and autophagosome formation. However, evidence to support this is not solid (e.g., evaluation of cells overexpressing the phospho-mimetic mutant, including expression levels, localization etc are missing, and Figure 8A is especially open-ended).

We have assessed the relative expression levels of the WIPI2B wild type, phosphomimetic and nonphosphorylatable constructs; we did not detect differences in expression among the different WIPI2B constructs (Figure 7---figure supplement 1E). Furthermore, when we select neurons to image, we always choose neurons expressing the constructs within the same narrow range of low fluorescence intensity. Since fluorescent signal is directly correlated to expression levels for these constructs, we can be certain that we are assessing neurons expressing similar levels of each of the WIPI2B constructs. We have clarified our explanation of this in the Materials and methods. We have also improved the clarity of our presentation of the data on cellular localization of these constructs, including Figure 8A -- now Figure 7H-J in the revised manuscript.

![](elife-44219-resp-fig5){#respfig5}

As addressed above, we have now added additional data characterizing the phospho-specific antibody and the expression levels (Figure 7---figure supplement 1E) and localization of the phospho-mimetic (Figure 7H) and nonphosphorylatable mutant WIPI2B constructs (Figure 7I-J, 8D). We tested both phospho-WIPI2 antibodies against HeLa lysates expressing each of the Halo-WIPI2B constructs (Figure 7---figure supplement 1C). Since Wan et al., 2018 Mol Cell already tested the phospho-WIPI2 antibody from CST (13571), we performed the suggested negative control with the novel antibody (316BP2). In all of these experiments, the phospho-WIPI2 antibodies detected Halo-WIPI2B WT, but neither of the phospho point mutants, which is consistent with what Wan et al., 2018 found. Additionally, we performed the siRNA experiment as suggested, expressing both phospho-WIPI2 constructs simultaneously. We were not able to see sequential recruitment because Halo-WIPI2B(S395A) remained stuck at the puncta. We have included these data in the revised manuscript in Figure 8C.

> One possible experiment the authors could do is to express WIPI2B (S395A) and WIPI2B (S395E) in the presence of siRNA for endogenous WIPI2 to test if these two forms of WIPI2B are recruited to the forming autophagosome in a sequential manner.

This was a great suggestion. We could not detect recruitment of the S395A and S395E constructs in a sequential manner because we noted that the S395A construct appears to be retained on the membrane. We then quantified the retention time for each construct and now include the resulting data in Figure 8C.

> Importantly, the authors must test their pWIPI2 antibodies specificity using a negative control, e.g., immunoprecipitated WIPI2 phospho-null mutant.

These data have been added to Figure 7---figure supplement 1C-D. Our data are consistent with Wan et al., 2018 Mol Cell.

> The authors describe that age-dependent defects on autophagosome biogenesis are likely due to aberrant post-translational modification of WIPI2 rather than WIPI2 levels. How can they explain that WIPI2 overexpression then rescues age-dependent defects? This point must be discussed in detail.

Higher levels of WIP2B expression are likely to increase the cellular concentration of the unphosphorylated form, which is required for successful biogenesis.

> Reviewer \#2:
>
> 1\) Although not absolutely required, it would be nice to get some numbers to support the conclusions drawn based on Figure 1 C-J that aged neurons show more aberrant autophagic vesicles.

As noted above, we now provide a quantitative analysis of our EM data. By EM analysis, we find that 80.4% of autophagosomes in the distal tips of primary DRG neurons are morphologically normal, significantly different from the 34.0% that are morphologically normal in neurons from aged mice (n=56 from young neurons, n=153 from aged neurons; p\<0.0001). See [Author response image 1](#respfig1){ref-type="fig"}.

> 2\) Both the text and the figure legends of several figures (e.g. Figure 2 and3) fail to mention that quantification of puncta formed is based on live-cell imaging of neurons transfected with fluorescent constructs. The figures should also be clearly labeled with the protein analyzed (e.g. Figure 2B-D should be labeled mCherry-ATG13 instead of ATG13) for the reader to know if one is looking av transfected or endogenous protein. They should also explain (at least in the Materials and methods) how the quantifications (rate of formation) were done.

To quantify AV formation, we examined the GFP-LC3B channel in our time-lapse videos. A biogenesis event was defined as the de novo generation of a LC3B punctum or the growth of a punctum that was present at the start of the video acquisition (growth in terms of visible expansion of the area of the punctum). Since the latter category only applies to the puncta present at the start of the video, the vast majority of the events quantified were de novo GFP-LC3B puncta (that also grew during the time lapse). We have clarified this point in the Materials and methods section of the revised manuscript.

> 3\) To confirm that the reduced level of autophagosome formation seen with age is real, and not due to reduced level of transfection in aged neurons, the authors should show by western blot that the level of transfection is equal for young and old neurons. Moreover, they should confirm their data using staining for endogenous proteins (LC3).

Please see Figure 7---figure supplement 1E for the western blot showing equivalent levels of overexpression of Halo-WIPI2B with age in DRGs. However, western blot analysis only indicates overexpression levels at a whole-plate level. During imaging, we are careful to select neurons within a narrow range of fluorescence intensity. Since fluorescence intensity is directly correlated to construct expression, we are imaging and analyzing neurons expressing roughly equivalent amounts of WIPI2.

We also examined endogenous levels of several autophagy components in whole brain and DRG lysates; see Figure 6---figure supplement 1 for WIPIs, see Figure 6---figure supplement 2 for mAtg8s and other autophagy proteins.

If the reviewer is referring to the autophagy flux assay, we performed this assay on DRG cultures overexpressing the WIPI2B constructs and saw no change in autophagic flux. However, as explained above, primary neuron cultures exhibit low transfection efficiency, so we are not surprised that there was no change in autophagic flux.

> 4\) In Figure 4E-F, the authors nicely show the presence of stalled AVs in vivo in old mice, as detected by colocalization of ATG9 and ATG13. They should also show that these structures lack LC3B to confirm their in vitro data.

Unfortunately, this experiment is not technically possible due to the limited number of independent channels and sources of dependable, IF/ICC-capable antibodies. LC3A and LC3B are especially problematic, as many antibodies that purport to be isoform-specific bind both isoforms. As our data indicate that LC3A is capable of being recruited to stalled AVs, we would need a stringently LC3B-specific antibody to perform this experiment properly.

> 5\) In Figure 6 the authors ask if WIPI2 could be involved in the stalling phenotype of AVs seen in neurons from aged mice. They should first show if WIPI2 is recruited or not to stalled AVs, as they have done for all other autophagy markers. Now, they directly shown the importance of WIPI2 and its binding to PI3P and ATG16L1 in autophagosome biogenesis in primary neurons, which is nice and expected, but the transition would have been better if they could show 6E-H before A-D (at least for WT WIPI2).

We appreciate the reviewer's advice, and we have wrestled with the presentation of this data, but we feel that it is most efficiently presented as is. We did include immunocytochemistry of endogenous WIPI2 in fixed DRG neurons from aged mice (Figure 5---figure supplement 1F), showing that WIPI2 is recruited to stalled AVs.

> 6\) In Figure 7 they show nicely that de-phosphorylation of WIPI2B at forming AVs seems to be required for recruitment of LC3B and AV biogenesis. However, they do not detect a difference in protein levels of total or phosphorylated WIPI2B with age and therefore propose that changes in cytosol/membrane levels of phosphorylated WIPI2B could change with age. This can be easily tested (and should be done) by a crude cytosol/membrane fractionation of their cell lysates or alternatively by gradient fractionation to see if the l specificity of membrane binding of P-WIPI2B is changed.

This was a great suggestion. As shown by the new data in Figure 8A-8B, we find that P-WIPI2 is significantly enriched in the cytosolic fraction of crude brain lysates in comparison to total WIPI2 levels. We see no change with age, as phospho-WIPI2 is more likely to be cytosolic than the total pool of WIPI2 in brain lysates from either young adult (3-month old) or aged (16-month old) mice. This observation fits with our hypothesis that the stalling observed in autophagosome biogenesis is a local event, due to local misregulation of WIPI2 phosphorylation. Our results regarding the residence time of the S395A versus S395E constructs also support this hypothesis.

Based on this experiment, we can extend our model to suggest that the recruitment of WIPI2B that is dephosphorylated at residue S395 is required to initiate autophagosome biogenesis (Figure 7D,E), but the local phosphorylation of WIPI2B at S395 is required to induce WIPI2B dissociation from membrane, concomitant with the growth of the nascent autophagosome (Figure 7F,G).

> From the blots in Figure S4 and S5 it seems like the majority of WIPI2B is phosphorylated and that the upper band of the WIPI2 blot correspond to the P-WIPI2 band. Is this correct?

The endogenous mouse proteins from brain, P-WIPI2 and WIPI2, co-migrate on SDS-PAGE. In HeLa cells overexpressing the constructs, we can see the phosphomimetic migrates slightly slower than the nonphosphorylatable construct. We ran a Phostag (Wako) western blot to determine the relative levels of phosphorylated and unphosphorylated WIPI2 in mouse brain. Phostag gels restrict migration of phosphorylated proteins, allowing distinction between the forms using a single antibody. Our data suggest that approximately half of the total WIPI2 in phosphorylated in mouse brain across ages.
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> 7\) Figure 7H; this figure is confusing. The authors claim that it shows a stalled AV where WIPI2B S395E is not recruited, but how do we know ATG5 and WIPI2B S395E are expressed?

We now state more clearly in both the main text and the legend that these images are taken from neurons expressing ATG5 and WIPI2B S395E. We also include the time lapse sequence of the whole distal axon in Figure 7---figure supplement 2 to clearly show that this neuron is expressing each construct.

> 8\) Figure 8B: the figure suggests a model where WIPI2B de-phosphorylation regulates its membrane recruitment and binding PI3P. To be able to conclude about this, they should do the membrane fractionation experiments suggested above and/or colocalization with PI3P.

As noted above, this was a great suggestion. The resulting data in the new Figure 8A-B, which indicate that phosphorylation of WIPI2 correlates with a decreased association with the membrane fraction from a brain lysate, further support the model in Figure 9 of the revised manuscript.

> 9\) Furthermore, the model indicates that WIPI2B de-phosphorylation is important for the initial membrane recruitment of LC3B (and AV biogenesis), while WIPI2B re-phosphorylation is required for growth of LC3B positive structures. Their data are however not of sufficient strength to conclude about this and they should consider to modify the model as well as the sentence stating: \" Further, we find that the dynamic regulation of WIPI2B phosphorylation at the isolation membrane is integral to autophagosome biogenesis, as our results suggest that dephosphorylated WIPI2B is required for recruitment of LC3B to the isolation membrane, while phosphorylated WIPI2B promotes expansion of the autophagosome\".

We have revised the sentence as suggested, to read "Further, we propose that the dynamic regulation of WIPI2B phosphorylation at the isolation membrane is integral to autophagosome biogenesis. Our results indicate that only the nonphosphorylatable S395A form of WIPI2B is sufficient to rescue depletion of endogenous WIPI2, while recruitment of the phosphomimetic WIPI2B S395E correlates with expansion of the autophagosome."

> 10\) It is puzzling that the WIPI2B S395E mutant is not recruited to the early structures, as there is no difference in recruitment of DFCP1 (showing the presence of PI3P) and ATG5-12-16L1. Is the WIPI2B S395E mutant able to interact with PI3P and ATG16L1?

Both we (Figure 7---figure supplement 1B) and others (Wan, et al., 2018 Mol Cell) have shown that the WIPI2B S395E mutant still interacts with PI3P and ATG16L1. However, our new results indicate that phospho-WIPI2B has a lower affinity for the membrane fraction, suggesting that the affinity of one or more of these interactions is altered by phosphorylation. We plan to follow up on this interesting observation in future, in mechanistic studies using more tractable model systems.

> Reviewer \#3:
>
> The data are generally quantified and statistics included (with description of which test used in the figure legends), but the authors should include more information about the software used for quantification of rate of AV formation.

Rates of AV formation were calculated from changes in fluorescent intensities and area over time using FIJI (Schindelin et al., 2012). The quantification was done manually; it was not automated. We have clarified this point in the Materials and methods section of the revised manuscript.

> This conclusion that autophagosome formation slows in aged mouse neurons is mainly supported by Figure 1 and Figure S1, which are quite convincing. Could the authors give more details about the definition of the rate of autophagosome biogenesis, i.e. LC3B puncta formation per min or mature autophagosome formation per min?

To quantify AV formation, we examined the GFP-LC3B channel in our time-lapse videos. A biogenesis event was defined as the de novo generation of a LC3B punctum or the growth of a punctum that was present at the start of the video acquisition (growth in terms of visible expansion of the area of the punctum). Since the latter category only applies to the puncta present at the start of the video, the vast majority of the events quantified were de novo GFP-LC3B puncta (that also grew during the time lapse). We did not quantify mature autophagosome formation. We have clarified this point in the Materials and methods section of the revised manuscript.

> Figure 2, Figure 3, and part of Figure 5 support the conclusions about the step at which the defect occurs. Figure 4 and 5 show that Atg9 is retained in the stalled autophagosomes, convincingly. These findings are also quite clear. I am curious about the destiny of the stalled autophagosomes. Are they eventually degraded by lysosomes? This should be discussed.

This is a great question and something we want to follow up on in more detail. We were able to image stalled events for up to 20 minutes, and in that time the stalled structures diffused locally within the tip and did not recruit GFP-LC3B. We were not able to image longer than 20 minutes due to photobleaching of the fluorophore.
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> Figure 6 contains the key rescue data. It is interesting that WIPI2B function depends on Atg16-binding, but the Atg16 recruitment is not affected in aged mouse neuron. Please discuss this.

While ATG16L1 is indeed recruited to stalled AVs, we cannot be certain that its function is unaffected at these stalled AVs. We wanted to examine ATG16L1 dynamics in live-cell imaging, but overexpressing ATG16 appears to disrupt autophagosome biogenesis (data not shown), as seen previously (Li et al., 2017, Autophagy). Of note, the C-terminus of ATG16L1 can compensate for depletion of WIPI2 to maintain lipidation during starvation in cell lines (Lystad et al., 2019, Nat Cell Biol).

\[Editors' note: further revisions were requested prior to acceptance, as described below.\]

> Essential revisions:
>
> Although the authors have convincingly shown that overexpression of WIPI2B or a phospho-null version of this protein in aged neurons restores autophagosome biogenesis, the sequential phosphorylation model of WIPI2B to control autophagosome biogenesis should be more carefully discussed and main messages on dynamics toned down.

We now more clearly and thoughtfully discuss our observations on WIPI2B phosphorylation, and the working model on dynamic phosphorylation during autophagosome biogenesis that we are proposing. As requested, we toned down the language used when discussing the model to make it clear that this is a working model that needs further experimental validation.

> 1\) Overexpression of both wild type or phospho-dead WIPI2(S395A) can rescue autophagosome biogenesis. How do the authors explain that a transition between dephosphorylation and phosphorylation is required for autophagosome biogenesis? The authors found that WIPI2 proteins levels increased with age in DRG neurons (Figure 6---figure supplement 1), but this result is discussed as if there is no change of WIPI2 levels with age. Combined with the observation that phosphorylation of WIPI2 is unchanged over time, this raises the possibility that overexpression of WIPI2 might not automatically lead to increases in phosphorylation (as argued by the authors in a rebuttal response). This brings about new questions, like how much (ie how many fold) is WIPI2 actually overexpressed in neurons compared to the age-associated increase observed, and has increases in WIPI2 phosphorylation (including over time) indeed been verified in this setting?

The only statistically significant change with age in WIPI2 protein levels was in DRG lysates from 1 mo-old mice and 24-mo-old mice. All other comparisons between ages were not significantly different. We do not conclude or model that phosphorylation of WIPI2 increases with age on a global or cellular level. In our rebuttal letter, we argued that overexpression of WIPI2 leads to increased nonphosphorylated WIPI2 available in the transfected neurons. If there was a typo in the rebuttal letter, we apologize for our mistake. Thus, we believe we agree with the reviewer on this point. We included immunoblot data of levels of WIPI2B overexpression in the first rebuttal letter that address the subsequent questions, but as noted we did not expect to see, nor did we see, increases in WIPI2 phosphorylation upon WIPI2B overexpression.

> 2\) In Figure 5 A-E, the authors used co-localization of ATG9 with ATG5 to identify stalled AV. However, while the authors showed representative pictures in Figure 5---figure supplement 1 that some LC3B homologs co-localize with both ATG9 and ATG5, the authors used ATG5 alone to identify stalled AV in Figure 5 F-J. It is possible that these vesicles may be functional autophagic vesicles with other LC3 homologs instead of LC3B. The authors may consider these as stalled AV as ATG5 stay long on the vesicle, but an alternative explanation may be that autophagic vesicles with other LC3 homologs have a different dynamics compared to that of LC3B.

We used ATG5 colocalization with ATG9 to define stalled AVs in fixed neurons, as we could not observe temporal dynamics. When we used live-cell microscopy (as in Figure 5F-J), we used ATG5 residence time to define stalled AVs, as co-transfecting 3 constructs is technically difficult and would necessitate the use of a fourth laser line (405 nm), which only works in our hands with highly expressed constructs or markers labeling large organelles. These stalled AVs have other mAtg8s on them, as demonstrated by labeling mAtg8s in Figure 5F-J. However, the presence of other mAtg8s does not appear sufficient to reduce ATG5 residence time to under 5 minutes, which is what we have observed in young adult neurons (Figure 3). We agree that the other mAtg8s may have different dynamics than LC3B. However, since ATG5 residence time is not reduced (and thus, as defined, these AVs are stalled AVs), presence of other mAtg8s is not sufficient to explain the deficit we observed.

> Figure 2L -- The number of ATG5-positive punctae were found to decrease over time, as now directly stated in the paper, but the significance of this result is not discussed at all.

As indicated in Figure 2L, we did find a statistically significant decrease in the rate of formation of ATG5 puncta in DRG neurons from 24 mo old mice, suggesting that at this late time point additional aspects of autophagosome biogenesis may be affected. We now note this observation in the text.

> 3\) Although the authors do not wish to make conclusions about their newly conducted flux assays, the provided diagram (which unfortunately is not accompanied with a figure legend, making it impossible to fully evaluate) may indicate that autophagy is still active in aged DRG neurons. If so, how would the authors explain the remaining autophagy activity with a decreased biogenesis of autophagosome vesicles in aged neurons?

A figure legend is now included below with the autophagic flux diagram initially provided in the first rebuttal letter.

As described in this work, we observed profound defects in autophagosome biogenesis, but do not see changes in bulk autophagy flux assays (see [Author response image 2](#respfig2){ref-type="fig"}). This could be because the classic autophagic flux assay is not sensitive enough to detect the decrease in axonal autophagosome biogenesis that we observe. However, as we mention in the Discussion section, other aspects of the autophagy pathway may be altered with age, as suggested by Bejarano et al. Changes in later steps to autophagy would affect the autophagic flux assay downstream from autophagosome biogenesis, potentially masking the deficit we observed. We are looking at these steps in detail in follow-up work.

> 4\) Missing data: Data showing ectopic overexpression of different mAtg8s to test LC3B recruitment to stalled AVs were not included, as requested by this reviewer -- this makes it impossible to evaluate the full experiment, including the negative data.

We missed the reviewer's point during the previous round of review. Figure 5---figure supplement 1, panel E, now includes data to address this point. Further, shown in [Author response image 8](#respfig8){ref-type="fig"} are western blot analysis of DRG cultures overexpressing the mAtg8s, demonstrating similar levels of expression.

![DRG neurons were harvested from 16-17 mo GFP-LC3B transgenic mice and co-transfected with the indicated mCherry-mAtg8 construct and Halo-ATG5 to mimic the imaging experiments.\
Neurons were grown for 2 DIV, harvested, and immunoblotted for mCherry. Total protein for each lane was quantified: 100, 47, 83, and 57 for each lane, from left to right.](elife-44219-resp-fig8){#respfig8}

However, as we discussed in the first response to reviewers, this is a measure of the entire population of cultured DRG neurons, few of which are actually transfected. In our actual imaging experiments, we select neurons to image within a narrow fluorescence range. As fluorescence intensity directly correlates with protein expression, we can be certain that we are imaging and analyzing neurons expressing roughly similar levels of each of the mAtg8s. The Materials and methods were revised to further clarify this point.

> Quantification data is missing in Figure 4E-F. Authors should provide how many events they have observed in young and old NMJs.

This quantification is now included in Figure 4G-I. The n values and relevant statistical information is provided in the Figure 4 figure legend.

> 5\) The authors\' argument not to cite Berjarano et al., 2018 because the study is not conducted in neurons is not valid. This study directly tested and showed, for the first time, an age-related decline in transport of autophagosomes, a conceptual advance that it relevant to this paper\'s findings, irrespective of cell type.

Bejarano et al., 2018 is now cited in the Discussion as requested.

[^1]: Department of Pathology, Yale University School of Medicine, New Haven, United States.
